0001019056-16-001402.txt : 20160712 0001019056-16-001402.hdr.sgml : 20160712 20160712133230 ACCESSION NUMBER: 0001019056-16-001402 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 48 CONFORMED PERIOD OF REPORT: 20151031 FILED AS OF DATE: 20160712 DATE AS OF CHANGE: 20160712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arax Holdings Corp CENTRAL INDEX KEY: 0001566243 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-EATING PLACES [5812] IRS NUMBER: 990376721 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 333-185928 FILM NUMBER: 161763670 BUSINESS ADDRESS: STREET 1: 2329 N. CAREER AVENUE STREET 2: SUITE 206 CITY: SIOUX FALLS STATE: SD ZIP: 57107 BUSINESS PHONE: 605-553-2238 MAIL ADDRESS: STREET 1: 2329 N. CAREER AVENUE STREET 2: SUITE 206 CITY: SIOUX FALLS STATE: SD ZIP: 57107 10-K/A 1 arax_10ka15.htm FORM 10-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

(Amendment No. 1)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended October 31, 2015

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________to _________

Commission File No. 333-185928

ARAX HOLDINGS CORP.

(Exact name of registrant as specified in its charter)

Nevada		2013		EIN 99-0376721
(State or Other Jurisdiction of Incorporation or Organization)		(Primary Standard Industrial Classification Number)		(IRS Employer Identification Number)

2329 N. Career Avenue

Suite 317

Sioux Falls, SD 57107

(605) 553 2238

(Address and telephone number of principal executive offices)

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes x No o

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant as required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes o No x*

*The registrant has filed all Exchange Act reports for the preceding 12 months.

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. Yes o No x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o	Accelerated filer o
Non-accelerated filer o	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes x No o

As of February 12, 2016, the registrant had 10,335,294 shares of common stock issued and outstanding. The aggregate market value of the common stock held by non-affiliates of the registrant at April 30, 2015 (the last business day of the registrant’s second fiscal quarter) was approximately $920,000. The aggregate market value was computed based upon 2,300,000 shares of common stock held by non-affiliates as of April 30, 2015 and a $0.40 closing price of the common stock as reported on the OTC QB Market on April 30, 2015. The closing price for the common stock on April 30, 2015 was used because the OTC QB Market reported no trades on that date and there was no active trading market for the registrant’s common stock in the subsequent two fiscal quarters.

EXPLANATORY NOTE

The purpose of this Amendment No. 1 (the “Amendment”) to the registrant’s Annual Report on Form 10-K for the year ended October 31, 2015, filed with the Securities and Exchange Commission on February 16, 2016 (the “Annual Report”), is to record related party payables due to two consultants under consulting agreements with Thru Pharma to be paid with 7,500 options for the first consultant on a monthly basis convertible at $.80 per share entered into in February 2015 and the other to be paid in 10,000 common shares as stock payable, and record a management estimate of 25% of their overall compensation as a consulting expense. The Company issued 600,000 warrants on September 22, 2015 as payment for legal expenses that had not been recorded. The Company also entered into a convertible note agreement that previously had not been recorded that is considered a derivative or contains embedded features subject to derivative accounting related to a revolving convertible note in which the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium totaling $37,500 which is added on 90 days after funding. The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881.

No other changes have been made to the Annual Report except as noted above. This Amendment to the Annual Report speaks as of the original filing date of the Annual Report, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Annual Report except that changes have been made to the cover page, Note 9 – Convertible Debt and Derivative Liabilities, Note 10 - Fair Value Measurement, Note 11 – Stock Purchase Options and Warrants, and Note 12 – Correction of Financial Statements.

ARAX HOLDINGS CORP.

FORM 10K/A

OCTOBER 31, 2015

TABLE OF CONTENTS


PART 1

ITEM 1	Description of Business	3
ITEM 1A	Risk Factors	4
ITEM 2	Description of Property	4
ITEM 3	Legal Proceedings	4
ITEM 4	Mine Safety Disclosures	4

PART II

ITEM 5	Market for Common Equity and Related Stockholder Matters	5
ITEM 6	Selected Financial Data	6
ITEM 7	Management’s Discussion and Analysis of Financial Condition and Results of Operations	6
ITEM 7A	Quantitative and Qualitative Disclosures about Market Risk	8
ITEM 8	Financial Statements and Supplementary Data	9
ITEM 9	Changes In and Disagreements with Accountants on Accounting and Financial Disclosure	F-18
ITEM 9A	Controls and Procedures	F-18

PART III

ITEM 10	Directors, Executive Officers, Promoters and Control Persons of the Company	F-20
ITEM 11	Executive Compensation	F-21
ITEM 12	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	F-21
ITEM 13	Certain Relationships and Related Transactions	F-22
ITEM 14	Principal Accountant Fees and Services	F-22

PART IV

ITEM 15	Exhibits	F-23
	Signatures	F-24

PART I

FORWARD-LOOKING STATEMENTS

This annual report contains forward-looking statements. These statements relate to future events or our future financial performance. These statements often can be identified by the use of terms such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “approximate” or “continue,” or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management’s best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

Item 1.

Description of Business

Arax Holdings Corp. (the “Company”, “we”, “our” or “us”) was incorporated under the laws of the State of Nevada on February 23, 2012 with a business plan to sell hot dogs from mobile hot dog stands throughout the major cities in Mexico. As of the filing of the 10K for last year, the Company stated that it was re-evaluating its business plan.

It was further indicated as possible that a new business model could be related to a new business sector other than the food sector, and that any new business model could entail a capital restructuring of the Company in order to provide new capital and a broader base of shareholders. Such a capital restructuring of the Company could involve a merger or acquisition of assets through various techniques, including a possible reverse-merger. At October 31, 2015, and as of the date of this filing, Management believes that the best business model for our investors is to pursue business activity in the Life Sciences sector of the United States and possibly internationally. We will continue to assess these opportunities and structures as well as the various pre-requisite actions needed to finalize and implement any new business model.

The Company is a majority-owned subsidiary of Thru Pharma, LLC, and these financials are presented on a stand-alone basis. All transactions with Thru Pharma have ben identified in Note: 4 and Note 5: Related party transactions.

Pursuant to a revision to a certain Consulting Agreement dated as of October 8, 2013, by and between Thru Pharma and Strategic Universal Advisors, LLC (“Strategic”), as amended effective January 17, 2014, on or about February 9, 2015, and most recently on October 20, 2015, with full effect as of April 1, 2015 (the “Consulting Agreement”), Thru Pharma and Strategic agreed that the intent of the Consulting Agreement ab initio was to provide Strategic with a 3% equity ownership of Thru Pharma in the event that a PUBCO M&A transaction did not occur prior to the end of the Consulting Agreement. Thru Pharma and Strategic agreed and stipulated that 753,504 shares of Arax Holdings would equal 3% of Thru Pharma as the equity payment under the Consulting Agreement, with transfer subject to the further provisions stated below. As Thru Pharma was the sole beneficiary of the services provided by Strategic under the Consulting Agreement, no part of the value of the consideration for services provided under the Consulting Agreement has been recognized as an expense by the Company.

In connection with earlier amendments to the Consulting Agreement, Strategic granted to Mr. Keough, a control person of the Company and Thru Pharma, an irrevocable proxy (the “Irrevocable Proxy”), to vote all of the common stock in the Company under certain conditions. That proxy no longer exists under the terms of the most recent amendment.

As part of the currently amended Consulting Agreement, Thru Pharma agreed to transfer 753,504 Company shares to Strategic upon the closing of a merger or acquisition (an “M&A Transaction”) of a public entity, resulting in Thru Pharma being the controlling owner of the entity that was the subject of the M&A Transaction, and Thru Pharma would cause such entity to also issue to Strategic a stock warrant to purchase 600,000 (six hundred thousand) shares of common stock of the entity that was the subject of the M&A Transaction. Such warrant will be of five-year duration, exercisable at $0.10 per share, and shall vest in four equal amounts of 150,000 shares with the first annual vesting to occur 60 (sixty) days following the completion of the PUBCO M&A Transaction, as well as other routine terms.

Notwithstanding anything to the contrary provided in the Consulting Agreement or elsewhere, in no event would Thru Pharma be directly and/or indirectly obligated to enter into or complete any particular M&A Transaction, including, but not limited to, any M&A Transaction with the Company.

Effective July 1, 2015, Arax and Catalyst Funding, LLC, entered into an Original Issue Discount Revolving Secured Convertible Promissory Note (the “Catalyst Note”) and a Securities Purchase Agreement (the “Catalyst SPA”). The transaction is secured by a grant of security interest to 100% of the Company stock held by or for Thru Pharma. The Catalyst Note and Catalyst SPA are intended to facilitate funding essential work relating to multi-year auditing of Thru Pharma financials. The total available funds are $200,000, and the Company has only drawn $75,000, and for which the Company is the obligor. A Commitment Fee of Company stock in the amount of 35,294 shares was authorized for issue to Catalyst as part of the transaction. In the event that the Company is unable to timely make payments under this agreement, Catalyst has the option of gaining control of the Thru Pharma shares in the Company.

The Company’s status as a “shell company” as of the date of this report remains unchanged.

Going Concern

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern. However, the Company has not generated any revenues as of October 31, 2015. The Company has incurred losses since Inception (February 23, 2012) resulting in an accumulated deficit of $442,409 as of October 31, 2015 and further losses are anticipated in the development of its business. The Company currently has no cash balance, a working capital deficit and stockholders’ deficit of $121,027 and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time.

The Company is dependent on additional investment capital to fund operating expenses. The Company intends to position itself so that it can be able to raise additional funds through the capital markets. In light of management’s efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

Item 1A.

Risk Factors

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

Item 2.

Description of Property

We do not own any real estate or other properties.

Item 3.

Legal Proceedings

On June 4, 2014, we were named as a defendant in a lawsuit filed by AMERIFINANCIAL, INC. (“AMERIFINANCIAL”), of Houston, Texas. The action related primarily to a contract dispute between AMERIFINANCIAL and our majority shareholder, Thru Pharma, LLC. The dispute did not allege any actions or inactions by our officers or representatives acting on our behalf. Counsel for Thru Pharma, LLC, requested that we be dismissed from this lawsuit, as we were not party to the disputed contract, and there was no legal basis for the Company being a part of the lawsuit. Accordingly, the Company did not recognize a liability in connection with the suit.

On August 31, 2015, the Judge in this Harris County, Texas, case ruled that the only remaining Defendant was Thru Pharma, LLC. Subsequent to our year end, on January 8, 2016, Thru Pharma and AMERIFINANCIAL, INC. reached settlement of the dispute.

Item 4.

Mine Safety Disclosures

Not applicable to our Company.

PART II

Item 5.

Market for Common Equity and Related Stockholder Matters

Market Information

Our shares of common stock are traded on the OTCBB under the symbol “ARAT.” Trading in stocks quoted on the OTC Bulletin Board is often thin and is characterized by wide fluctuations in trading prices due to many factors that may be unrelated to a company’s operations or business prospects. We cannot assure you that there will be a market in the future for our common stock.

OTC Bulletin Board securities are not listed or traded on the floor of an organized national or regional stock exchange. Instead, OTC Bulletin Board securities transactions are conducted through a telephone and computer network connecting dealers in stocks. OTC Bulletin Board issuers are traditionally smaller companies that do not meet the financial and other listing requirements of a regional or national stock exchange.

The following table sets forth the high and low trade information for our common stock for each quarter of the fiscal year ended October 31, 2015. As of October 31, 2014, the common stock was at $0.62. The first trade of our common stock this fiscal year was on November 3, 2014. No shares were traded during the fiscal quarters ended July 31, 2015 and October 31, 2015.

Quarter Ended	High		Low
January 31, 2015	$	0.62	$	0.52
April 30, 2015	$	0.52	$	0.40
July 31, 2015	$	0.40	$	0.40
October 31, 2015	$	0.40	$	0.40

No shares traded during Q3 and Q4. Bid price remained at $0.40.

Number of Holders

As of October 31, 2015, the 10,300,000 issued and outstanding shares of common stock were held by 37 total shareholders of record.

Dividends

No cash dividends were paid on our shares of common stock during the fiscal years ended October 31, 2015, 2014 and 2013. We have not paid any cash dividends since our inception and do not foresee declaring any cash dividends on our common stock in the foreseeable future.

Recent Sales of Unregistered Securities

No sales of unregistered securities were completed in the twelve months ended October 31, 2015.

Purchase of our Equity Securities by Officers and Directors

No purchase of equity securities took place in the twelve months ended October 31, 2015.

Other Stockholder Matters

None

Item 6.

Selected Financial Data

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Annual Report on Form 10-K (this “Report”) contains forward-looking statements which reflect management’s expectation or belief concerning future events that involve risks and uncertainties. Our actions, results and performance could differ materially from what is contemplated by the forward-looking statements contained in this Report. Factors that might cause differences from the forward-looking statements include those referred to or identified in our Registration Statement on Form S-1 filed with the SEC on April 25, 2013 and other factors that may be identified elsewhere in this Report. Reference should be made to such factors and all forward-looking statements are qualified in their entirety by the above cautionary statements.

The following is management’s discussion and analysis of the financial condition and results of operations of the Company, as well as our liquidity and capital resources. The discussion, including known trends and uncertainties identified by management, should be read in conjunction with the Company’s audited consolidated financial statements and related notes included in this Report. Our audited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.

Overview

Effective July 1, 2015, Arax and Catalyst Funding, LLC, entered into an Original Issue Discount Revolving Secured Convertible Promissory Note (the “Catalyst Note”) and a Securities Purchase Agreement (the “Catalyst SPA”). The transaction is secured by a grant of security interest to 100% of the Company stock held by or for Thru Pharma. The Catalyst Note and Catalyst SPA are intended to facilitate funding essential work relating to multi-year auditing of Thru Pharma financials. The total available funds are $200,000, and the Company has only drawn $75,000, and for which the Company is the obligor. A Commitment Fee of Company stock in the amount of 35,294 shares was authorized for issue to Catalyst as part of the transaction. In the event that the Company is unable to timely make payments under this Agreement, Catalyst has the option of gaining control of the Thru Pharma shares in the Company.

The Company’s status as a “shell company” as of the date of this report remains unchanged.

RESULTS OF OPERATIONS

We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation. We will require additional capital to meet our operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities. In light of management’s efforts, there are no assurances that we will be successful in this or any of our endeavors or become financially viable and continue as a going concern.

FISCAL YEAR ENDED OCTOBER 31, 2015 COMPARED TO FISCAL YEAR ENDED OCTOBER 31, 2014.

Revenue

We recognized no revenue during the twelve months ended October 31, 2015 and 2014 as we have not commenced revenue generating operations as yet.

Operating Expenses

During the fiscal year ended October 31, 2015, our operating expenses were $328,640 compared to $50,294 during the prior fiscal year. During the twelve months ended October 31, 2015, our operating expenses comprised professional fees of $328,640. By comparison, for the twelve months ended October 31, 2014, our operating expenses comprised professional fees of $49,813, bank service charges of $24, loss on disposal of an asset of $428 and depreciation expense of $29. Expenses incurred during the fiscal year ended October 31, 2015 compared to fiscal year ended October 31, 2014 increased primarily due to the issuance of options and warrants as compensation. Professional fees generally include financial and administrative contracted services.

Other Income (Expenses)

During the fiscal year ended October 31, 2015, our other income (expenses) were $23,616 compared to $0 during the prior fiscal year. During the twelve months ended October 31, 2015, our other income (expenses) comprised of interest expense of $18,116 from accrued interest on convertible notes and from the amortization of debt discount and OID, $25,434 in derivative expense, and $19,934 in change in fair value of derivative. By comparison, for the twelve months ended October 31, 2014 other income/(expenses) were $0.

Net Loss

Our net loss for the fiscal year ended October 31, 2015 was $352,256 compared to a net loss of $50,294 during the fiscal year ended October 31, 2014 due to the factors discussed above.

LIQUIDITY AND CAPITAL RESOURCES

As of October 31, 2015, our total assets were $0 and the Company had $114,417 of current liabilities comprised of $37,682 in loans from related parties, $69,312 in payments made in the form of convertible notes payable, net of discount, $1,923 in accrued interest payable, and $5,500 in derivative liability. As of October 31, 2014, our total assets were $0 and our total liabilities were $45,458 comprised of payables to a related party.

FISCAL YEAR ENDED OCTOBER 31, 2015 COMPARED TO FISCAL YEAR ENDED OCTOBER 31, 2014.

Cash Flows from Operating Activities

We have not generated positive cash flows from operating activities. During the fiscal year ended October 31, 2015, we used $29,774 in operating activities compared to $49,837 during the fiscal year ended October 31, 2014. The decrease between the two periods related primarily to the decrease in the loss due to non-cash professional fees as compared to the prior fiscal year.

Cash Flows from Investing Activities

We neither used nor generated cash flow from investing activities during the fiscal years ended October 31, 2015 or 2014.

Cash Flows from Financing Activities

During the fiscal year ended October 31, 2015, we received $29,774 by way of payments on our behalf by a related party to fund our working capital requirements, received $65,000 in proceeds from a convertible note, and made payments to related party totaling $65,000. During the fiscal year ended October 31, 2014, we received $46,085 by way of payments on our behalf by our then principal shareholder.

PLAN OF OPERATION AND FUNDING

Historically, we have funded working capital requirements primarily through the proceeds of the private placement of equity instruments and by way of loans from related parties. Our working capital requirements are expected to increase as our business grows. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) personnel; (ii) developmental expenses associated with a start-up business; and (iii) marketing expenses. We expect that working capital requirements will be funded through advances or payables on our behalf from Thru Pharma, and through further issuances of our securities.

We have no lines of credit or other bank financing arrangements. Additional issuances of equity or issuances of convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to implement our business plan.

MATERIAL COMMITMENTS

As of the date of this Annual Report, we do not have any material commitments.

PURCHASE OF SIGNIFICANT EQUIPMENT

We do not intend to purchase any significant equipment during the next twelve months.

OFF-BALANCE SHEET ARRANGEMENTS

As of the date of this Annual Report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

GOING CONCERN

The independent auditors’ report accompanying our October 31, 2015 and October 31, 2014 financial statements contains an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. The financial statements have been prepared “assuming that we will continue as a going concern,” which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business.

Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

Item 8.

Financial Statements and Supplementary Data

INDEX TO FINANCIAL STATEMENTS

TABLE OF CONTENTS

FOR THE TWELVE MONTHS ENDED OCTOBER 31, 2015 AND 2014

Report of Independent Registered Public Accounting Firm	F - 1 and F - 2

Balance Sheets as of October 31, 2015 and 2014	F - 3

Statements of Operations for the years ended October 31, 2015 and 2014	F - 4

Statement of Changes in Stockholders’ Deficit for the years ended October 31, 2015 and 2014	F - 5

Statements of Cash Flows for the years ended October 31, 2015 and 2014	F - 6

Notes to the Financial Statements	F - 7 - F - 17

(CUTLER CO LLC LOGO)

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors

Arax Holdings Corp.

2329 N. Career Avenue, Suite 317
Sioux Falls, South Dakota, 57107

We have audited the accompanying balance sheet of Arax Holdings Corp. as of October 31, 2014 and the related statement of operations, changes in stockholders’ deficit and cash flows for the year then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Arax Holdings Corp. as of October 31, 2014, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements the Company has suffered losses from operations since Inception (February 23, 2012) and currently does not have sufficient available funding to fully implement its business plan. These factors raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

-s- Cutler & Co., LLC

Cutler & Co., LLC

Wheat Ridge, formerly Denver, Colorado

February 13, 2015

9605 West 49^th Ave. Suite 200 Wheat Ridge, Colorado 80033 ~ Phone 303-968-3281 ~ Fax 303.456.7488 www.cutlercpas.com

F-1

Pritchett, Siler & Hardy, P.C.

Certified Public Accountants

1438 N Highway 89, Suite 130

Farmington, UT 84025

Office: (801)447-9572 Fax: (801)447-9578

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors

Arax Holdings Corp.

2329 N. Career Avenue, Suite 317

Sioux Falls, South Dakota, 57107

We have audited the accompanying balance sheets of Arax Holdings Corp. as of October 31, 2015 and the related statements of operations, changes in stockholders’ equity and cash flows for the year then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audit.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Arax Holdings Corp. as of October 31, 2015 and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has suffered continuing losses and has yet to establish a reliable, consistent and proven source of revenue to meet its operating costs on an ongoing basis and currently does not have sufficient available funding to fully implement its business plan. These factors raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Pritchett, Siler and Hardy PC

Pritchett, Siler and Hardy PC

Farmington Utah

February 16, 2016

Except for Notes 8 and 12, which are July 8, 2016

F-2

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Arax Holdings Corp.

Balance Sheets

	October 31, 2015			October 31, 2014
	(Restated)
ASSETS

Current assets	$	—		$	—
Total current assets
		—			—
TOTAL ASSETS	$	—		$	—

LIABILITIES AND STOCKHOLDERS’ DEFICIT

Current liabilities:
Loans from related party	$	37,682		$	45,458
Convertible Notes payable, net of $43,188 debt discount		69,312			—
Accrued Interest Payable		1,923			—
Derivative Liability		5,500			—
Total current liabilities		114,417			45,458

Total liabilities		114,417			45,458

Stockholders’ deficit:

Common stock, $0.001 par value; 75,000,000 shares authorized; 10,300,000 shares issued and outstanding		10,300			10,300
Additional paid-in capital		258,564			25,548
Stock Subscription Payable		50,281			—
Accumulated deficit		(433,562	)		(81,306	)
Total stockholders’ deficit	$	(114,417	)	$	(45,458	)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	—		$	—

See accompanying notes to financial statements.

F-3

Arax Holdings Corp.

Statements of Operations


	For the Year Ended			For the Year Ended
	October 31, 2015			October 31, 2014
	(Restated)
REVENUE	$	—		$	—

OPERATING EXPENSES
Depreciation expense		—			29
Bank service charges		—			24
Professional fees		328,640			49,813
Loss on disposal of fixed assets		—			428
TOTAL OPERATING EXPENSES		328,640			50,294

NET LOSS FROM OPERATIONS		(328,640	)		(50,294	)

OTHER INCOME (EXPENSES)
Interest Expense		(18,116	)		—
Derivative Expense		(25,434	)		—
Change in Fair Value of Derivative		19,934			—
TOTAL OTHER INCOME (EXPENSES)		(23,616	)		—

NET LOSS BEFORE INCOME TAXES		(352,256	)		(50,294	)

Provision for Income Taxes		—			—

NET LOSS		(352,256	)		(50,294	)

NET LOSS PER SHARE: BASIC AND DILUTED	$	(0.03	)	$	(0.00	)*

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED		10,300,000			10,300,000

*Denotes a loss of less than $(0.01) per share

See accompanying notes to financial statements.

F-4

Arax Holdings Corp.

Statement of Changes in Stockholders’ Deficit

For the years ended October 31, 2015 and 2014

					Additional		Stock					Total
	Common Stock				Paid In		Subscription		Accumulated			Stockholders’
	Shares		Amount		Capital		Payable		Deficit			Deficit
Balances, October 31, 2013		10,300,000	$	10,300	$	20,700	$	—	$	(31,012	)	$	(12	)

Forgiveness of related party loan payable		—		—		4,848		—		—			4,848
Net loss for the period		—		—		—		—		(50,294	)		(50,294	)

Balances, October 31, 2014		10,300,000	$	10,300	$	25,548	$	—	$	(81,306	)	$	(45,458	)

Stock as Incentive for Convertible Note		—		—		—		11,881		—			11,881
Stock for Compensation		—		—		—		38,400		—			38,400
Options Granted for Compensation		—		—		16,217		—		—			16,217
Warrants Issued for Compensation		—		—		216,799		—		—			216,799
Net loss for the period		—		—		—		—		(352,256	)		(352,256	)

Balances, October 31, 2015		10,300,000	$	10,300	$	258,564	$	50,281	$	(433,562	)	$	(114,417	)

See accompanying notes to financial statements.

F-5

Arax Holdings Corp.

Statements of Cash Flows

	For the Year Ended			For the Year Ended
	October 31, 2015			October 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the period	$	(361,103	)	$	(50,294	)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock for Compensation		38,400			—
Derivative Expense		25,434			—
Related party payable for services		27,450			—
Options granted for compensation		16,217			—
Warrants issued for professional fees		216,799			—
Change in Fair Value of Derivative		(19,934	)		—
Amortization of debt discount and Original Issue Discount		16,193			—
Depreciation expense		—			29
Loss on disposal of fixed assets		—			428
Changes in Assets and Liabilities:
Accrued Interest Payable		1,923			—
NET CASH USED IN OPERATING ACTIVITIES		(29,774	)		(49,837	)

CASH FLOWS FROM INVESTING ACTIVITIES:
NET CASH FLOWS FROM INVESTING ACTIVITIES:		—			—

CASH FLOWS FROM FINANCING ACTIVITIES:
Loan from related party		29,774			46,085
Proceeds from convertible note		65,000			—
Payments to related party		(65,000	)		—
NET CASH FLOWS FROM FINANCING ACTIVITIES:		29,774			46,085

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS		—			(3,752	)

CASH, BEGINNING OF PERIOD		—			3,752

CASH, END OF PERIOD	$	—		$	—

SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid		—			—
Income taxes paid		—			—

SUPPLEMENTAL SCHEDULE OF NON-CASH
INVESTING AND FINANCING ACTIVITIES:
Original Issue Discount	$	10,000		$	—
Stock as Incentive for Convertible Note	$	11,881		$	—
Disposal of equipment without cash proceeds	$	—		$	428
Forgiveness of loan from related party	$	—		$	4,848
TOTAL NON-CASH INVESTING AND FINANCING ACTIVITIES	$	21,881		$	5,276

See accompanying notes to financial statements.

F-6

ARAX HOLDINGS CORP.

NOTES TO THE FINANCIAL STATEMENTS

FOR THE TWELVE MONTHS ENDED OCTOBER 31, 2015 AND 2014

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

The Company is a majority-owned subsidiary of Thru Pharma, LLC, and these financials are presented on a stand-alone basis. All transactions with Thru Pharma have been identified in Note 4: Stockholders’ deficit and Note 5: Related party transactions.

Pursuant to a revision to a certain Consulting Agreement dated as of October 8, 2013, by and between Thru Pharma and Strategic Universal Advisors, LLC (“Strategic”), as amended effective January 17, 2014, on or about February 9, 2015, and most recently on October 20, 2015, with full effect as of April 1, 2015 (the “Consulting Agreement”), Thru Pharma and Strategic agreed that the intent of the Consulting Agreement ab initio was to provide Strategic with a 3% equity ownership of Thru Pharma n the event that a PUBCO M&A transaction di not occur prior to the end of the Consulting Agreement. Thru Pharma and Strategic agreed and stipulated that 753,504 shares of Arax Holdings would equal 3% of Thru Pharma as the equity payment under the Consulting Agreement, with transfer subject to the further provisions stated below. As Thru Pharma was the sole beneficiary of the services provided by Strategic under the Consulting Agreement, no part of the value of the consideration for services provided under the Consulting Agreement has been recognized as an expense by the Company.

Effective July 1, 2015, Arax and Catalyst Funding, LLC, entered into an Original Issue Discount Revolving Secured Convertible Promissory Note (the “Catalyst Note”) and a Securities Purchase Agreement (the “Catalyst SPA”). The transaction is secured by a grant of security interest to 100% of the Company stock held by or for Thru Pharma. The Catalyst Note and Catalyst SPA are intended to facilitate funding essential work relating to multi-year auditing of Thru Pharma financials. The total potentially available funds are $200,000, and the Company has only drawn $75,000, and for which the Company is the obligor. A Commitment Fee of Company stock in the amount of 35,294 shares was authorized for issue to Catalyst as part of the transaction. In the event that the Company is unable to timely make payments under this Agreement, Catalyst has the option of gaining control of the Thru Pharma shares in the Company.

The Company’s status as a “shell company” as of the date of this report remains unchanged.

F-7

NOTE 2 – GOING CONCERN

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern. However, the Company has not generated any revenues as of October 31, 2015. The Company has incurred losses since Inception (February 23, 2012) resulting in an accumulated deficit of $433,562 as of October 31, 2015 and further losses are anticipated in the development of its business. The Company currently has no cash balance, a working capital deficit and stockholders’ deficit of $114,417 and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in United States of America and are presented in US dollars. The Company has adopted an October 31 fiscal year end.

Development Stage Company

The Company is in the development stage as defined under the then current Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 915-205 “Development-Stage Entities” and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders’ deficit and cash flows disclosed activity since the date of its Inception (February 23, 2012) as a development stage company. Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents.

Fair Value of Financial Instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

F-8

The following are the hierarchical levels of inputs to measure fair value:

	•	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
	•	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	•	Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.

Embedded Conversion Features

The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature.

Debt Issue Costs and Debt Discount

The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.

Original Issue Discount

For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.

Income Taxes

Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.

The Company accounts for income taxes under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740, “Accounting for Income Taxes”. It prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As a result, the Company has applied a more-likely-than-not recognition threshold for all tax uncertainties. The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities. The Company is subject to taxation in the United States. All of the Company’s tax years are subject to examination by Federal and state jurisdictions.

The Company classifies penalties and interest related to income taxes as income tax expense in the Statements of Operations.

F-9

Basic Income (Loss) Per Share

Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the Company’s net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There were no such common stock equivalents outstanding during the years ending October 31, 2015 and 2014.

Recent Accounting Pronouncements

The Company has reviewed all the recent accounting pronouncements issued to date of the issuance of these financial statements, and does not believe any of these pronouncements will have a material impact on the company.

NOTE 4 – STOCKHOLDERS’ DEFICIT

Common Stock

The Company is authorized to issue 75,000,000 shares of common stock with a par value of $0.001 per share.

The Company had 10,300,000 shares of common stock issued and outstanding as of October 31, 2015.

Additional Paid in Capital

During the year ended October 31, 2015, the Company issued 37,500 stock purchase options for a value of $16,217, issued 600,000 stock purchase warrants for a value of $216,799.

Stock Subscription Payable

During the year ended October 31, 2015, the Company owed 35,294 of the Company’s common stock as incentive to enter into a convertible note with a value of $11,881 and 110,000 shares of the Company’s common stock as compensation for Thru Pharma related party expense valued at $38,400 for a total stock subscription payable of $50,281.

F-10

NOTE 5 – RELATED PARTY TRANSACTIONS

In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders or directors. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note.

The Company owed its majority shareholder, Thru Pharma, a total of $37,682 as of October 31, 2015, in the form of a related party payable. It is due on demand and is non-interest bearing.

NOTE 6 – INCOME TAXES

Income taxes are accounted for under the assets and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled.

As of October 31, 2015, the Company had a net operating loss carry-forward of approximately $433,562 that may be used to offset future taxable income and begins to expire in 2031. Because of the change in ownership that occurred on January 16, 2014, net operating loss carry forwards could be limited as to use in future years.

NOTE 7 – COMMITMENTS AND CONTINGENCIES

Legal

NOTE 8 – SUBSEQUENT EVENTS

In accordance with ASC 855-10, “Subsequent Events” the Company has analyzed its operations subsequent to October 31, 2015 to the date these financial statements were issued. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881.

NOTE 9 – CONVERTIBLE DEBT AND DERIVATIVE LIABILITIES

The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting related to a revolving convertible note in which the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium which is added on 90 days after funding. The note is to be paid off in installments of $19,453 for six months after the ninety day period. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has estimated the fair value of these embedded derivatives for convertible debentures using a multinomial lattice model as of July 31, 2015 and October 31, 2015.

The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%.

F-11

NOTE 10 – FAIR VALUE MEASUREMENT

The Company uses the multinomial lattice model to calculate the fair value of the derivative liability.

Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of October 31, 2015 and 2014 consisted of the following:

	Fair Value Measurements Using
Description	Total Fair Value at October 31, 2015		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Derivative liability	$	5,500	$	—	$	5,500	$	—

	Fair Value Measurements Using
Description	Total Fair Value at October 31, 2014		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
None	$	—	$	—	$	—	$	—

NOTE 11 - STOCK PURCHASE OPTIONS AND WARRANTS

During the year ended October 31, 2015, the Company issued options to purchase a total of 37,500 shares of the Company’s Common Stock. The Company issued 37,500 options in conjunction with a consulting agreement entered into in February 2015. According to the consulting agreement, the company is to issue either 5,000 common shares or 7,500 options per month during the duration of their agreements. The options were valued using the multinomial lattice pricing model under the assumptions noted below.

Stock Purchase Options

During the year ended October 31, 2015, the Company issued 37,500 stock purchase options for a value of $16,217.

During the year ended October 31, 2014, the Company did not issue any stock purchase options.

The following table presents the assumptions used to estimate the fair values of the stock warrants and options granted:

	2015			2014
Expected volatility		202-213	%		N/A
Expected dividends		0	%		N/A
Expected term		3 Years			N/A
Risk-free interest rate		0.80-1.09	%		N/A

F-12

The following table summarizes the changes in options outstanding of the Company during the year ended October 31, 2015.

Date Issued	Number of Options		Weighted Average Exercise Price		Weighted Average Grant Date Fair Value		Expiration Date (yrs)		Value if Exercised
Balance as of October 31, 2014		—	$	—	$	—		—	$	—
Granted		37,500		0.80		0.41		2.64		30,000
Exercised		—		—		—		—		—
Cancelled/Expired		—		—		—		—		—
Outstanding as of October 31, 2015		37,500	$	0.80	$	0.41		2.47	$	30,000

Stock Purchase Warrants

During the year ended October 31, 2015, the Company issued warrants to purchase a total of 600,000. The Company issued 600,000 warrants in conjunction with a consulting agreement entered into in July 2015. The warrants were valued using the multinomial lattice pricing model under the assumptions noted below.

During the year ended October 31, 2015, the Company issued 600,000 stock purchase warrants for a value of $216,799.

During the year ended October 31, 2014, the Company did not issue any stock purchase warrants.

The following table presents the assumptions used to estimate the fair values of the stock warrants and options granted:

	2015			2014
Expected volatility		212	%		N/A
Expected dividends		0	%		N/A
Expected term		3 Years			N/A
Risk-free interest rate		1.08	%		N/A

The following table summarizes the changes in warrants outstanding issued to employees and non-employees of the Company during the year ended October 31, 2015.

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Grant Date Fair Value		Expiration Date (yrs)		Value if Exercised

Outstanding as of October 31, 2014		—	$	—	$	—		—	$	—
Granted		600,000		0.80		0.36		2.73		480,000
Exercised		—		—		—		—		—
Cancelled/Expired		—		—		—		—		—
Outstanding as of October 31, 2015		600,000	$	0.80	$	0.36		2.73	$	480,000

F-13

NOTE 12 – RESTATEMENT OF FINANCIAL STATEMENTS

This Amendment No. 1 corrects our previously issued financial statements for the year ended October 31, 2015, to record related party payable due to two consultants relating to consulting agreements to be paid with 7,500 options for the first consultant on a monthly basis convertible at $.80 per share entered into in February 2015 and the other to be paid in 10,000 common shares as stock payable. The Company issued 600,000 warrants on September 22, 2015 as payment for legal expenses that had not been recorded. The Company also entered into a convertible note agreement that previously had not been recorded that is considered a derivative or contains embedded features subject to derivative accounting related to a revolving convertible note where the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium totaling $37,500 which is added on 90 days after funding. The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881.

The effects of these corrections on the financial statements are as follows:

Arax Holdings Corp.
Balance Sheets
October 31, 2015

	As Reported			Correction			As Restated
Loans from related party	$	75,232		$	(37,550	)	$	37,682
Convertible Notes payable, net of $43,188 debt discount		—			69,312			69,312
Accrued Interest Payable		—			1,923			1,923
Derivative Liability		—			5,500			5,500
Total current liabilities		75,232			39,185			114,417
Total liabilities		75,232			39,185			114,417
Stock Subscription Payable		—			50,281			50,281
Accumulated deficit		(111,080	)		(322,482	)		(433,562	)
Total stockholders’ deficit	$	(111,080	)	$	(3,337	)	$	(114,417	)

F-14

Arax Holdings Corp.
Statements of Operations
Year Ended October 31, 2015

	As Reported			Correction			As Restated

Professional Fees	$	29,774		$	298,866		$	328,640
TOTAL OPERATING EXPENSES		29,774			298,866			328,640
NET LOSS FROM OPERATIONS		(29,774	)		(298,866	)		(328,640	)
Interest Expense		—			(18,116	)		(18,116	)
Derivative Expense		—			(25,434	)		(25,434	)
Change in Fair Value of Derivative		—			19,934			19,934
TOTAL OTHER INCOME		—			(23,616	)		(23,616	)
NET LOSS BEFORE INCOME TAXES		(29,774	)		(322,482	)		(352,256	)
NET LOSS		(29,774	)		(322,482	)		(352,256	)
NET LOSS PER SHARE: BASIC AND DILUTED	$	(0.00	)	$	(0.03	)	$	(0.03	)

F-15

Arax Holdings Corp.
Statements of Changes in Stockholders’ Deficit
For the year ended October 31, 2015

	Additional Paid In		Stock Subscription		Accumulated			Total Stockholders’
As Reported	Capital		Payable		Deficit			Deficit
Stock as Incentive for Convertible Note	$	—	$	—	$	—		$	—
Stock for Compensation		—		—		—			—
Options Granted for Compensation		—		—		—			—
Warrants Issued for Compensation		—		—		—			—
Net loss for the period		—		—		(29,774	)		(29,774	)
Balances, October 31, 2015	$	25,548		—	$	(111,080	)	$	(75,232	)

Correction
Stock as Incentive for Convertible Note	$	—	$	11,881	$	—		$	11,881
Stock for Compensation		—		38,400		—			38,400
Options Granted for Compensation		16,217		—		—			16,217
Warrants Issued for Compensation		216,799		—		—			216,799
Net loss for the period		—		—		(322,482	)		(322,482	)
Balances, October 31, 2015	$	233,016	$	50,281	$	(322,482	)	$	(39,185	)

As Corrected
Stock as Incentive for Convertible Note	$	—	$	11,881	$	—		$	11,881
Stock for Compensation		—		38,400		—			38,400
Options Granted for Compensation		16,217		—		—			16,217
Warrants Issued for Compensation		216,799		—		—			216,799
Net loss for the period		—		—		(352,256	)		(352,256	)
Balances, October 31, 2015	$	258,564	$	50,281	$	(433,562	)	$	(114,417	)

F-16

Arax Holdings Corp.
Statements of Cash Flows
Year Ended October 31, 2015

	As Reported			Correction			As Restated
Net loss for the period	$	(29,774	)	$	(322,482	)	$	(352,256	)
Stock For Compensation		—			38,400			38,400
Derivative Liability addition		—			25,434			25,434
Related party payable for services		—			27,450			27,450
Options granted for compensation		—			16,217			16,217
Warrants issued for professional fees		—			216,799			216,799
Change in Fair Value of Derivative		—			(19,934	)		(19,934	)
Amortization of debt discount		—			16,193			16,193
Accrued Interest Payable		—			1,923			1,923
NET CASH USED IN OPERATING ACTIVITIES		(29,774	)		—			(29,774	)

Proceeds from Convertible Note		29,774			—			29,774
Proceeds from Convertible Note		—			65,000			65,000
Payments to related party		—			(65,000	)		(65,000	)
NET CASH FLOWS FROM FINANCING ACTIVITIES		29,774			—			29,774
Original Issue Discount	$	—		$	10,000		$	10,000
Stock as Incentive for Convertible Note	$	—		$	11,881		$	11,881
TOTAL NON-CASH INVESTING AND FINANCING ACTIVITIES	$	—		$	21,881		$	21,881

F-17

Item 9.

Changes In and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures (as defined in Rule 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

The Company’s management carried out an evaluation, under the supervision and with the participation of its Chief Executive Officer and its Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures as of October 31, 2015. Based upon this evaluation, our management concluded that the Company’s disclosure controls and procedures were not effective as of October 31, 2015.

Management’s Annual Report on Internal Control over Financial Reporting.

Our internal control over financial reporting is a process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets; provide reasonable assurance that transactions are recorded as necessary to permit preparation of our financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with the authorization of our board of directors and management; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of October 31, 2015, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

F-18

We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

We did not maintain appropriate cash controls – As of October 31, 2015, the Company has not maintained sufficient internal controls over financial reporting for the cash process, including failure to segregate cash handling and accounting functions, and did not require dual signature on the Company’s bank accounts. Alternatively, the effects of poor cash controls were mitigated by the fact that the Company had limited transactions in their bank accounts.

We did not implement appropriate information technology controls – As at October 31, 2015, the Company retains copies of all financial data and material agreements; however there is no formal procedure or evidence of normal backup of the Company’s data or off-site storage of data in the event of theft, misplacement, or loss due to unmitigated factors.

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the Company’s internal controls.

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of October 31, 2015 based on criteria established in Internal Control — Integrated Framework issued by COSO.

This Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management’s report in this Annual Report on Form 10-K.

Changes in Internal Control Over Financial Reporting.

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected or is reasonably likely to materially affect, our internal control over financial reporting. Management plans to routinely assess its internal control over financial reporting against appropriate standards, and to make changes as determined necessary and according to the scope of business operations.

F-19

PART III

Item 10.

Directors, Executive Officers, Promoters and Control Persons of the Company

DIRECTORS AND EXECUTIVE OFFICERS

The name, address and position of our present officers and directors are set forth below:

Name and Address of Executive
Officer and/or Director	Age	Position

Steven J. Keough	60	Chairman, President, Secretary,
2329 N. Career Avenue, Suite 317		Treasurer and Director
Sioux Falls, South Dakota, 57107

Mr. Keough is the Chairman and Chief Executive Officer of THRU PHARMA, LLC, a related party to the Company. He received his Bachelor of Science degree from the U.S. Naval Academy (Annapolis, MD), his Master of Arts degree from the Catholic University of America (Washington, D.C.) and his Juris Doctorate degree from Boston College Law School (Newton, MA.). He is the recipient of a financial management certificate from the University of Chicago Graduate School of Business. Mr. Keough was Senior Vice President of a NASDAQ-listed company, SurModics, during a vibrant growth period of that company. He may only be devoting limited time to our operations, and our operations may be sporadic and occur at times which are convenient to him. As a result, operations may be periodically interrupted or suspended which could result in a lack of revenues and a cessation of operations.

AUDIT COMMITTEE

We do not have an audit committee financial expert. We do not have an audit committee financial expert because we believe the cost related to retaining a financial expert at this time is prohibitive. Further, because we have no operations, at the present time, we believe the services of a financial expert are not warranted.

SIGNIFICANT EMPLOYEES

We have no employees other than our sole director, Steven Keough who currently devotes minimal time per week to company matters. We intend to hire employees on an as-needed basis.

F-20

Item 11.

Executive Compensation

The following tables set forth certain information about compensation paid, earned or accrued for services by our President, and Secretary and all other executive officers (collectively, the “Named Executive Officers”) for the years ended October 31, 2014 and 2015.

SUMMARY COMPENSATION TABLE

Name and Principal Position	Salary (US$)		Bonus (US$)		Stock Awards (US$)		Option Awards (US$)		Non-Equity Incentive Plan Compensation (US$)		Nonqualified Deferred Compensation Earnings (US$)		All Other Compensation (US$)		Total (US$)
2015 Steven J Keough *		0		0		0		0		0		0		0		0

*CEO, President, CFO/Treasurer, Secretary

2014 Steven J Keough *		0		0		0		0		0		0		0		0

As of October 31, 2015, we had no pension plans or compensatory plans or other arrangements that provide compensation in the event of a termination of employment or a change in our control.

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table provides certain information regarding the ownership of our common stock, as of October 31, 2015 and as of the date of the filing of this annual report by:


•	each of our executive officers;
•	each director;
•	each person known to us to own more than 5% of our outstanding common stock; and
•	all of our executive officers and directors and as a group.

F-21

The percent of class is based on 10,300,000 shares of common stock issued and outstanding as of the date of this annual report.

Item 13.

Certain Relationships and Related Transactions

During the year ended October 31, 2015, we borrowed $29,774 and accrued expenses of $27,450 from our shareholder, Thru Pharma, in the form of a related party payable. We also made payments of $65,000 on the related party payable. It is due on demand and is non-interest bearing.

Item 14.

Principal Accountant Fees and Services

During fiscal year ended October 31, 2015, we incurred approximately $8,950 in fees to our principal independent accountants for professional services rendered in connection with the audit of our financial statements and for the reviews of our financial statements for the quarters ended January 31, 2015, April 30, 2015 and July 31, 2015. This compares to approximately $7,750 in fees during fiscal year ended October 31, 2014 in connection with the audit of our financial statements and for the reviews of our financial statements for the quarters ended January 31, 2014, April 30, 2014, and July 31, 2014.

F-22

Item 15.

Exhibits

The following exhibits are filed as part of this Annual Report.

Exhibits:

31.1	Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act

32.1	Certification of Chief Executive Officer and Chief Financial Officer Under Section 1350 as Adopted Pursuant Section 906 of the Sarbanes-Oxley Act

32.1	Certification of Chief Executive Officer and Chief Financial Officer Under Section 1350 as Adopted Pursuant Section 906 of the Sarbanes-Oxley Act

101.INS XBRL Instance Document (furnished herewith)*

101.SCH XBRL Taxonomy Extension Schema Document (furnished herewith)*

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document (furnished herewith)*

101.DEF XBRL Taxonomy Extension Definition Linkbase Document (furnished herewith)*

101.LAB XBRL Taxonomy Extension Label Linkbase Document (furnished herewith)*

101.PRE XBRL Taxonomy Extension Presentation Linkbase Document (furnished herewith)*

F-23

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		ARAX HOLDINGS CORP.

Dated: July 12, 2016	By:	/s/ Steven J. Keough
		Steven J. Keough, Chairman, President, Chief Executive Officer and Chief Financial Officer and Secretary

F-24

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

Exhibit 31.1

Rule 13a-14(a)/Rule 15d-14(a) Certification of Principal Executive Officer and Principal Financial Officer

I, Steven J. Keough, certify that:

1. I have reviewed this annual report on Form 10-K/A of Arax Holdings Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements and other financial information included in this report fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 12, 2016		/s/ Steven J. Keough
		Steven J. Keough, Principal Executive Officer and Principal Financial Officer

EX-32.1 3 ex32_1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION
PURSUANT TO 18 U.S.C.
Sec.1350,

AS ADOPTED
PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Arax Holdings Corp. (the “Company”) on Form 10-K/A for the period ended October 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Steven J. Keough, Principal Executive Officer and Principal Financial Officer of the registrant, certifies, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that:

1. The Report on Form 10-K/A fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented in the Report.

Date: July 12, 2016	By:	/s/ Steven J. Keough
	Name:	Steven J. Keough
	Title:	Principal Executive Officer and Principal Financial Officer

GRAPHIC 4 araxa001_v1.jpg GRAPHIC begin 644 araxa001_v1.jpg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end GRAPHIC 5 araxa002_v1.jpg GRAPHIC begin 644 araxa002_v1.jpg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end EX-101.INS 6 fil-20151031.xml XBRL INSTANCE FILE 0001566243 2015-10-31 0001566243 2014-10-31 0001566243 us-gaap:CommonStockMember 2013-10-31 0001566243 us-gaap:AdditionalPaidInCapitalMember 2013-10-31 0001566243 us-gaap:ParentMember 2013-10-31 0001566243 us-gaap:AdditionalPaidInCapitalMember 2013-11-01 2014-10-31 0001566243 us-gaap:ParentMember 2013-11-01 2014-10-31 0001566243 us-gaap:CommonStockMember 2014-10-31 0001566243 us-gaap:AdditionalPaidInCapitalMember 2014-10-31 0001566243 us-gaap:ParentMember 2014-10-31 0001566243 us-gaap:AdditionalPaidInCapitalMember 2014-11-01 2015-10-31 0001566243 us-gaap:ParentMember 2014-11-01 2015-10-31 0001566243 us-gaap:CommonStockMember 2015-10-31 0001566243 us-gaap:AdditionalPaidInCapitalMember 2015-10-31 0001566243 us-gaap:ParentMember 2015-10-31 0001566243 2014-11-01 2015-10-31 0001566243 2013-11-01 2014-10-31 0001566243 2013-10-31 0001566243 fil:ThruPharmaMember 2015-10-31 0001566243 2015-04-30 0001566243 us-gaap:RetainedEarningsMember 2013-11-01 2014-10-31 0001566243 us-gaap:RetainedEarningsMember 2014-11-01 2015-10-31 0001566243 us-gaap:RetainedEarningsMember 2013-10-31 0001566243 us-gaap:RetainedEarningsMember 2014-10-31 0001566243 us-gaap:RetainedEarningsMember 2015-10-31 0001566243 2016-02-12 0001566243 fil:StockSubscriptionPayableMember 2014-11-01 2015-10-31 0001566243 fil:StockSubscriptionPayableMember 2015-10-31 0001566243 us-gaap:FairValueInputsLevel1Member 2015-10-31 0001566243 us-gaap:FairValueInputsLevel1Member 2014-10-31 0001566243 us-gaap:FairValueInputsLevel2Member 2015-10-31 0001566243 us-gaap:FairValueInputsLevel2Member 2014-10-31 0001566243 us-gaap:FairValueInputsLevel3Member 2015-10-31 0001566243 us-gaap:FairValueInputsLevel3Member 2014-10-31 0001566243 us-gaap:StockOptionMember 2015-10-31 0001566243 us-gaap:StockOptionMember 2014-11-01 2015-10-31 0001566243 us-gaap:StockOptionMember 2014-10-31 0001566243 us-gaap:WarrantMember 2015-10-31 0001566243 us-gaap:WarrantMember 2014-11-01 2015-10-31 0001566243 us-gaap:WarrantMember 2014-10-31 0001566243 us-gaap:StockOptionMember 2013-11-01 2014-10-31 0001566243 us-gaap:WarrantMember 2013-11-01 2014-10-31 0001566243 us-gaap:ScenarioPreviouslyReportedMember 2015-10-31 0001566243 us-gaap:RestatementAdjustmentMember 2015-10-31 0001566243 us-gaap:ScenarioPreviouslyReportedMember 2014-11-01 2015-10-31 0001566243 us-gaap:RestatementAdjustmentMember 2014-11-01 2015-10-31 0001566243 us-gaap:AdditionalPaidInCapitalMember us-gaap:ScenarioPreviouslyReportedMember 2014-11-01 2015-10-31 0001566243 us-gaap:AdditionalPaidInCapitalMember us-gaap:RestatementAdjustmentMember 2014-11-01 2015-10-31 0001566243 fil:StockSubscriptionPayableMember us-gaap:ScenarioPreviouslyReportedMember 2014-11-01 2015-10-31 0001566243 fil:StockSubscriptionPayableMember us-gaap:RestatementAdjustmentMember 2014-11-01 2015-10-31 0001566243 us-gaap:RetainedEarningsMember us-gaap:ScenarioPreviouslyReportedMember 2014-11-01 2015-10-31 0001566243 us-gaap:RetainedEarningsMember us-gaap:RestatementAdjustmentMember 2014-11-01 2015-10-31 0001566243 us-gaap:ParentMember us-gaap:ScenarioPreviouslyReportedMember 2014-11-01 2015-10-31 0001566243 us-gaap:ParentMember us-gaap:RestatementAdjustmentMember 2014-11-01 2015-10-31 0001566243 us-gaap:AdditionalPaidInCapitalMember us-gaap:ScenarioPreviouslyReportedMember 2015-10-31 0001566243 us-gaap:AdditionalPaidInCapitalMember us-gaap:RestatementAdjustmentMember 2015-10-31 0001566243 fil:StockSubscriptionPayableMember us-gaap:ScenarioPreviouslyReportedMember 2015-10-31 0001566243 fil:StockSubscriptionPayableMember us-gaap:RestatementAdjustmentMember 2015-10-31 0001566243 us-gaap:RetainedEarningsMember us-gaap:ScenarioPreviouslyReportedMember 2015-10-31 0001566243 us-gaap:RetainedEarningsMember us-gaap:RestatementAdjustmentMember 2015-10-31 0001566243 us-gaap:ParentMember us-gaap:ScenarioPreviouslyReportedMember 2015-10-31 0001566243 us-gaap:ParentMember us-gaap:RestatementAdjustmentMember 2015-10-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 10-K/A 2015-10-31 true Arax Holdings Corp 0001566243 --10-31 Smaller Reporting Company Yes No No 2015 FY -114417 -45458 10300 20700 -12 10300 25548 -45458 10300 258564 -114417 -31012 -81306 -433562 50281 -111080 -3337 25548 252642 0 50281 -111080 -322482 -75232 -39185 -50294 0 -352256 -352256 -50294 -50294 -352256 0 -29774 -322482 0 0 0 0 -29774 -322482 -29774 -322482 0 0 0 0 37682 45458 75232 -37550 114417 45458 75232 39185 114417 45458 75232 39185 10300 10300 258564 25548 0 0 0.001 0.001 75000000 75000000 10300000 10300000 10300000 10300000 0 0 0 29 0 24 328640 49813 29774 298866 0 -428 328640 50294 29774 298866 -328640 -50294 -29774 -298866 0 0 -.03 -0.00 -0.00 -.03 10300000 10300000 -433562 -81306 -111080 -322482 10355294 920000 -361103 -50294 -29774 -322482 0 -428 0 29 -29774 -49837 -29774 0 0 0 29774 46085 29774 0 29774 46085 0 0 0 3752 0 -3752 0 0 0 0 21881 5276 0 21881 4848 4848 0 4848 0 428 10300000 10300000 10300000 10232 81306 Net operating loss carry-forward may be used to offset future taxable income and begins to expire in 2031.   The purpose of this Amendment No. 1 (the Amendment) to the registrants Annual Report on Form 10-K for the year ended October 31, 2015, filed with the Securities and Exchange Commission on February 16, 2016 (the Annual Report), is to record related party payables due to two consultants under consulting agreements with Thru Pharma to be paid with 7,500 options for the first consultant on a monthly basis convertible at $.80 per share entered into in February 2015 and the other to be paid in 10,000 common shares as stock payable, and record a management estimate of 25% of their overall compensation as a consulting expense. The Company issued 600,000 warrants on September 22, 2015 as payment for legal expenses that had not been recorded. The Company also entered into a convertible note agreement that previously had not been recorded that is considered a derivative or contains embedded features subject to derivative accounting related to a revolving convertible note in which the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium totaling $37,500 which is added on 90 days after funding. The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881.   No other changes have been made to the Annual Report except as noted above. This Amendment to the Annual Report speaks as of the original filing date of the Annual Report, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Annual Report except that changes have been made to the cover page, Note 9 Convertible Debt and Derivative Liabilities, Note 10 - Fair Value Measurement, Note 11 Stock Purchase Options and Warrants, and Note 12 Correction of Financial Statements. 1923 0 0 1923 5500 0 0 5500 50281 0 0 50281 69312 0 0 69312 41797 0 19934 0 0 19934 -23616 0 0 -23616 -352256 -50294 -29774 -322482 18116 0 0 18116 0 11881 11881 0 11881 0 11881 0 0 0 11881 0 0 0 11881 16217 16217 16217 0 0 0 0 16217 0 16217 0 0 0 0 0 61277 216799 216799 216799 0 0 0 0 216799 0 216799 0 0 0 0 0 216799 1923 0 0 1923 16193 0 0 16193 65000 0 29774 0 65000 0 0 65000 10000 0 0 10000 5500 0 0 0 5500 0 0 0 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">202-213%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: left">Expected dividends</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">N/A</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3 Years</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.80-1.09%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td></tr> </table>    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2015</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">2014</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Expected volatility</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">212</td><td style="width: 1%; text-align: left">%</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">N/A</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividends</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3 Years</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.08</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td></tr> </table> 2.03 2.13 0.00 0.00 P3Y .0080 .0109 2.12 .0108 37500 0 600000 0 37500 600000 0 0 0 0 .80 0.00 .80 0.00 .80 .80 0.00 0.00 0.00 0.00 .41 .00 .36 0.00 .41 .36 0.00 0.00 0.00 0.00 P0Y P0Y P2Y7M20D P8M23D P2Y5M19D P8M23D 30000 0 480000 0 30000 480000 25434 0 0 -25434 38400 38400 0 38400 0 38400 27450 0 27450 Arax Holdings Corp. (the Company, we, our or us) was incorporated under the laws of the State of Nevada on February 23, 2012 with a business plan to sell hot dogs from mobile hot dog stands throughout the major cities in Mexico. As of the filing of the 10K for last year, the Company stated that it was re-evaluating its business plan.   It was further indicated as possible that a new business model could be related to a new business sector other than the food sector, and that any new business model could entail a capital restructuring of the Company in order to provide new capital and a broader base of shareholders. Such a capital restructuring of the Company could involve a merger or acquisition of assets through various techniques, including a possible reverse-merger. At October 31, 2015, and as of the date of this filing, Management believes that the best business model for our investors is to pursue business activity in the Life Sciences sector of the United States and possibly internationally. We will continue to assess these opportunities and structures as well as the various pre-requisite actions needed to finalize and implement any new business model.   The Company is a majority-owned subsidiary of Thru Pharma, LLC, and these financials are presented on a stand-alone basis. All transactions with Thru Pharma have been identified in Note 4: Stockholders deficit and Note 5: Related party transactions.   Pursuant to a revision to a certain Consulting Agreement dated as of October 8, 2013, by and between Thru Pharma and Strategic Universal Advisors, LLC (Strategic), as amended effective January 17, 2014, on or about February 9, 2015, and most recently on October 20, 2015, with full effect as of April 1, 2015 (the Consulting Agreement), Thru Pharma and Strategic agreed that the intent of the Consulting Agreement ab initio was to provide Strategic with a 3% equity ownership of Thru Pharma n the event that a PUBCO M&A transaction di not occur prior to the end of the Consulting Agreement. Thru Pharma and Strategic agreed and stipulated that 753,504 shares of Arax Holdings would equal 3% of Thru Pharma as the equity payment under the Consulting Agreement, with transfer subject to the further provisions stated below. As Thru Pharma was the sole beneficiary of the services provided by Strategic under the Consulting Agreement, no part of the value of the consideration for services provided under the Consulting Agreement has been recognized as an expense by the Company.   In connection with earlier amendments to the Consulting Agreement, Strategic granted to Mr. Keough, a control person of the Company and Thru Pharma, an irrevocable proxy (the Irrevocable Proxy), to vote all of the common stock in the Company under certain conditions. That proxy no longer exists under the terms of the most recent amendment.   As part of the currently amended Consulting Agreement, Thru Pharma agreed to transfer 753,504 Company shares to Strategic upon the closing of a merger or acquisition (an M&A Transaction) of a public entity, resulting in Thru Pharma being the controlling owner of the entity that was the subject of the M&A Transaction, and Thru Pharma would cause such entity to also issue to Strategic a stock warrant to purchase 600,000 (six hundred thousand) shares of common stock of the entity that was the subject of the M&A Transaction. Such warrant will be of five-year duration, exercisable at $0.10 per share, and shall vest in four equal amounts of 150,000 shares with the first annual vesting to occur 60 (sixty) days following the completion of the PUBCO M&A Transaction, as well as other routine terms.   Notwithstanding anything to the contrary provided in the Consulting Agreement or elsewhere, in no event would Thru Pharma be directly and/or indirectly obligated to enter into or complete any particular M&A Transaction, including, but not limited to, any M&A Transaction with the Company.   Effective July 1, 2015, Arax and Catalyst Funding, LLC, entered into an Original Issue Discount Revolving Secured Convertible Promissory Note (the Catalyst Note) and a Securities Purchase Agreement (the Catalyst SPA). The transaction is secured by a grant of security interest to 100% of the Company stock held by or for Thru Pharma. The Catalyst Note and Catalyst SPA are intended to facilitate funding essential work relating to multi-year auditing of Thru Pharma financials. The total potentially available funds are $200,000, and the Company has only drawn $75,000, and for which the Company is the obligor. A Commitment Fee of Company stock in the amount of 35,294 shares was authorized for issue to Catalyst as part of the transaction. In the event that the Company is unable to timely make payments under this Agreement, Catalyst has the option of gaining control of the Thru Pharma shares in the Company.   The Companys status as a shell company as of the date of this report remains unchanged. In support of the Companys efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders or directors. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note.   The Company owed its majority shareholder, Thru Pharma, a total of $37,682 as of October 31, 2015, in the form of a related party payable. It is due on demand and is non-interest bearing. Legal   On June 4, 2014, we were named as a defendant in a lawsuit filed by AMERIFINANCIAL, INC. (AMERIFINANCIAL), of Houston, Texas. The action related primarily to a contract dispute between AMERIFINANCIAL and our majority shareholder, Thru Pharma, LLC. The dispute did not allege any actions or inactions by our officers or representatives acting on our behalf. Counsel for Thru Pharma, LLC, requested that we be dismissed from this lawsuit, as we were not party to the disputed contract, and there was no legal basis for the Company being a part of the lawsuit. Accordingly, the Company did not recognize a liability in connection with the suit.   On August 31, 2015, the Judge in this Harris County, Texas, case ruled that the only remaining Defendant was Thru Pharma, LLC. Subsequent to our year end, on January 8, 2016, Thru Pharma and AMERIFINANCIAL, INC. reached settlement of the dispute. In accordance with ASC 855-10, Subsequent Events the Company has analyzed its operations subsequent to October 31, 2015 to the date these financial statements were issued. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881. The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting related to a revolving convertible note in which the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium which is added on 90 days after funding. The note is to be paid off in installments of $19,453 for six months after the ninety day period. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Companys balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has estimated the fair value of these embedded derivatives for convertible debentures using a multinomial lattice model as of July 31, 2015 and October 31, 2015.   The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%. During the year ended October 31, 2015, the Company issued options to purchase a total of 37,500 shares of the Companys Common Stock. The Company issued 37,500 options in conjunction with a consulting agreement entered into in February 2015. According to the consulting agreement, the company is to issue either 5,000 common shares or 7,500 options per month during the duration of their agreements. The options were valued using the multinomial lattice pricing model under the assumptions noted below. Stock Purchase Options  During the year ended October 31, 2015, the Company issued 37,500 stock purchase options for a value of $16,217.    During the year ended October 31, 2014, the Company did not issue any stock purchase options.   The following table presents the assumptions used to estimate the fair values of the stock warrants and options granted:  <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2015</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">202-213</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">N/A</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 58%">Expected dividends</td> <td style="width: 5%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">0</td> <td style="width: 1%">%</td> <td style="width: 5%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">N/A</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 Years</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">N/A</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk-free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">0.80-1.09</td> <td>% </td> <td> </td> <td> </td> <td style="text-align: right">N/A</td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="width: 100%; text-align: center">F-12</td></tr> <tr> <td style="text-align: center"> </td></tr> </table> The following table summarizes the changes in options outstanding of the Company during the year ended October 31, 2015.  <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-left: 8.65pt; text-align: center; text-indent: -8.65pt">Date Issued</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Number of Options</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Expiration Date (yrs)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Value if Exercised</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Balance as of October 31, 2014</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 40%; padding-left: 8.65pt; text-indent: -8.65pt">Granted</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">37,500</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">0.80</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">0.41</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">2.64</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">30,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Exercised</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 8.65pt; text-indent: -8.65pt">Cancelled/Expired</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Outstanding as of October 31, 2015</td> <td> </td> <td> </td> <td style="text-align: right">37,500</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">0.80</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">0.41</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.47</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">30,000</td> <td> </td></tr> </table> Stock Purchase Warrants  During the year ended October 31, 2015, the Company issued warrants to purchase a total of 600,000. The Company issued 600,000 warrants in conjunction with a consulting agreement entered into in July 2015. The warrants were valued using the multinomial lattice pricing model under the assumptions noted below.  During the year ended October 31, 2015, the Company issued 600,000 stock purchase warrants for a value of $216,799.    During the year ended October 31, 2014, the Company did not issue any stock purchase warrants.   The following table presents the assumptions used to estimate the fair values of the stock warrants and options granted:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2015</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 58%">Expected volatility</td> <td style="width: 5%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">212</td> <td style="width: 1%">%</td> <td style="width: 5%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">N/A</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected dividends</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">N/A</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 Years</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">N/A</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk-free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.08</td> <td>%</td> <td> </td> <td> </td> <td style="text-align: right">N/A</td> <td> </td></tr> </table> The following table summarizes the changes in warrants outstanding issued to employees and non-employees of the Company during the year ended October 31, 2015.  <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 8.65pt; text-align: center; text-indent: -8.65pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Number of Warrants</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Expiration Date (yrs)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Value if Exercised</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-align: center; text-indent: -8.65pt"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Outstanding as of October 31, 2014</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 40%; padding-left: 8.65pt; text-indent: -8.65pt">Granted</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">600,000</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">0.80</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">0.36</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">2.73</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">480,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Exercised</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 8.65pt; text-indent: -8.65pt">Cancelled/Expired</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Outstanding as of October 31, 2015</td> <td> </td> <td> </td> <td style="text-align: right">600,000</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">0.80</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">0.36</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.73</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">480,000</td> <td> </td></tr> </table> The Company uses the multinomial lattice model to calculate the fair value of the derivative liability.    Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of October 31, 2015 and 2014 consisted of the following:    <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: black 1pt solid; text-align: center">Fair Value Measurements Using</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="border-bottom: black 1pt solid">Description</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Fair Value at October 31, 2015</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Quoted Prices in Active Markets (Level 1)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Significant Unobservable Inputs (Level 3)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 52%; padding-bottom: 1pt; text-align: justify">Derivative liability</td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">5,500</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right"></td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">5,500</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right"></td> <td style="width: 1%; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: black 1pt solid; text-align: center">Fair Value Measurements Using</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Description</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Fair Value at October 31, 2014</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Quoted Prices in Active Markets (Level 1)</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Significant Unobservable Inputs (Level 3)</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="text-align: justify">None</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: black 1pt solid; text-align: center">Fair Value Measurements Using</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="border-bottom: black 1pt solid">Description</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Fair Value at October 31, 2015</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Quoted Prices in Active Markets (Level 1)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Significant Unobservable Inputs (Level 3)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 52%; padding-bottom: 1pt; text-align: justify">Derivative liability</td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">5,500</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right"></td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">5,500</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right"></td> <td style="width: 1%; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: black 1pt solid; text-align: center">Fair Value Measurements Using</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Description</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Fair Value at October 31, 2014</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Quoted Prices in Active Markets (Level 1)</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Significant Unobservable Inputs (Level 3)</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="text-align: justify">None</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="border-bottom: black 1pt solid; padding-left: 8.65pt; text-align: center; text-indent: -8.65pt">Date Issued</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Number of Options</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Expiration Date (yrs)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Value if Exercised</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Balance as of October 31, 2014</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 40%; padding-left: 8.65pt; text-indent: -8.65pt">Granted</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">37,500</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">0.80</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">0.41</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">2.64</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">30,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Exercised</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 8.65pt; text-indent: -8.65pt">Cancelled/Expired</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Outstanding as of October 31, 2015</td> <td> </td> <td> </td> <td style="text-align: right">37,500</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">0.80</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">0.41</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.47</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">30,000</td> <td> </td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-left: 8.65pt; text-align: center; text-indent: -8.65pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Number of Warrants</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Exercise Price</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Expiration Date (yrs)</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Value if Exercised</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; text-align: center; text-indent: -8.65pt"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Outstanding as of October 31, 2014</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 40%; padding-left: 8.65pt; text-indent: -8.65pt">Granted</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">600,000</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">0.80</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">0.36</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">2.73</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">480,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Exercised</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 8.65pt; text-indent: -8.65pt">Cancelled/Expired</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-left: 8.65pt; text-indent: -8.65pt">Outstanding as of October 31, 2015</td> <td> </td> <td> </td> <td style="text-align: right">600,000</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">0.80</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">0.36</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.73</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">480,000</td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Arax Holdings Corp.</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Balance Sheets</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">October 31, 2015</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Reported</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Correction</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Restated</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 64%">Loans from related party</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">75,232</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">(37,550</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">37,682</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Convertible Notes payable, net of $36,578 debt discount</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">75,922</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">75,922</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Accrued Interst Payable</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,923</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,923</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Derivative Liability</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">5,500</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">5,500</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 1pt">Total current liabilities</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">75,232</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">45,795</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">121,027</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total liabilities</td> <td> </td> <td> </td> <td style="text-align: right">75,232</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">45,795</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">121,027</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Stock Subscription Payable</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">52,518</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">52,518</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Accumulated deficit</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(111,080</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(331,329</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(442,409</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 2.5pt">Total stockholders deficit</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(111,080</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(9,947</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(121,027</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>     <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Arax Holdings Corp.</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Statements of Operations</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Year Ended October 31, 2015</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Reported</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Correction</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Restated</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 64%; padding-bottom: 1pt">Professional Fees</td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">29,774</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">298,866</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">328,640</td> <td style="width: 1%; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">TOTAL OPERATING EXPENSES</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">29,774</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">298,866</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">328,640</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>NET LOSS FROM OPERATIONS</td> <td> </td> <td> </td> <td style="text-align: right">(29,774</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(298,866</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(328,640</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Interest Expense</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(26,963</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(26,963</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 1pt">Derivative Expense</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(25,434</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: right">(25,434</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Change in Fair Value of Derivative</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">19,934</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">19,934</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 1pt">TOTAL OTHER INCOME</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(32,463</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(32,463</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>NET LOSS BEFORE INCOME TAXES</td> <td> </td> <td> </td> <td style="text-align: right">(29,774</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(331,329</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(361,103</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 2.5pt">NET LOSS</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(29,774</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(331,329</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(361,103</td> <td style="padding-bottom: 2.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">NET LOSS PER SHARE: BASIC AND DILUTED</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.00</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.04</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.04</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>     <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="17" style="text-align: center">Arax Holdings Corp</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="17" style="text-align: center">Statements of Changes in Stockholders Deficit</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center">Additional Paid In</td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center">Stock Subscription</td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center">Accumulated</td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center">Total Stockholders</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-bottom: 1pt; text-decoration: underline">As Reported</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Capital</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Payable</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Deficit</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Deficit</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td nowrap="nowrap">Stock as Incentive for Convertible Note</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap">Stock for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Options Granted for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants Issued for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 52%; padding-bottom: 1pt">Net loss for the period</td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right"></td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right"></td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">(29,774</td> <td style="width: 1%; padding-bottom: 1pt">)</td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">(29,774</td> <td style="width: 1%; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balances, October 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">25,548</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"></td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">($</td> <td style="border-bottom: black 2.25pt double; text-align: right">111,080</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">($</td> <td style="border-bottom: black 2.25pt double; text-align: right">75,232</td> <td style="padding-bottom: 2.5pt">)</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="text-decoration: underline">Correction</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock as Incentive for Convertible Note</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">14,118</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">14,118</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Stock for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Options Granted for Compensation</td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Warrants Issued for Compensation</td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Net loss for the period</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(331,329</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(331,329</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 2.5pt">Balances, October 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">233,016</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">52,518</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">($</td> <td style="border-bottom: black 2.25pt double; text-align: right">331,329</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">($</td> <td style="border-bottom: black 2.25pt double; text-align: right">45,795</td> <td style="padding-bottom: 2.5pt">)</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-decoration: underline">As Corrected</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Stock as Incentive for Convertible Note</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">14,118</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">14,118</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Options Granted for Compensation</td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants Issued for Compensation</td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 1pt">Net loss for the period</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(361,103</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(361,103</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balances, October 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">258,564</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">52,518</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">($</td> <td style="border-bottom: black 2.25pt double; text-align: right">442,409</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">($</td> <td style="border-bottom: black 2.25pt double; text-align: right">121,027</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>     <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Arax Holdings Corp.</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Statements of Cash Flows</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Year Ended October 31, 2015</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Reported</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Correction</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Restated</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 64%">Net loss for the period</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">(29,774</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">(331,329</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">(361,103</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock For Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Stock as Incentive for Convertible Note</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">14,118</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">14,118</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Derivative Liability addition</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">25,434</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">25,434</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Options granted for compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants issued for professional fees</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Change in Fair Value of Derivative</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(19,934</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(19,934</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Amortization of debt discount</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">10,922</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">10,922</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Accrued Interest Payable</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,923</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,923</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Proceeds from Convertible Note</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">65,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">65,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Payments to related party</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(65,000</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(65,000</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Original Issue Discount</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">10,000</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">10,000</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 2.5pt">TOTAL NON-CASH INVESTING AND FINANCING ACTIVITIES</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right"></td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">10,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">10,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   The accompanying financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern. However, the Company has not generated any revenues as of October 31, 2015. The Company has incurred losses since Inception (February 23, 2012) resulting in an accumulated deficit of $433,562 as of October 31, 2015 and further losses are anticipated in the development of its business. The Company currently has no cash balance, a working capital deficit and stockholders deficit of $114,417 and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time.   The Company is dependent on additional investment capital to fund operating expenses. The Company intends to position itself so that it can be able to raise additional funds through the capital markets. In light of managements efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern. Basis of Presentation   The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in United States of America and are presented in US dollars. The Company has adopted an October 31 fiscal year end.   Development Stage Company   The Company is in the development stage as defined under the then current Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 915-205 Development-Stage Entities and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders deficit and cash flows disclosed activity since the date of its Inception (February 23, 2012) as a development stage company. Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required.   Use of Estimates   The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.   Cash and Cash Equivalents   The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents.   Fair Value of Financial Instruments   The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.  The following are the hierarchical levels of inputs to measure fair value:    <table cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 45px; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"> </td> <td style="vertical-align: top; width: 45px; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify">Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.</td></tr> <tr> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"> </td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify">Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</td></tr> <tr> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"> </td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify">Level 3 - Unobservable inputs reflecting the Companys assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</td></tr> </table>   The carrying amounts of the Companys financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.    The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.     Embedded Conversion Features   The Company evaluates embedded conversion features within convertible debt under ASC 815 Derivatives and Hedging to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 Debt with Conversion and Other Options for consideration of any beneficial conversion feature.    Debt Issue Costs and Debt Discount   The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.    Original Issue Discount   For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.    Income Taxes   Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.   The Company accounts for income taxes under the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 740, Accounting for Income Taxes. It prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As a result, the Company has applied a more-likely-than-not recognition threshold for all tax uncertainties. The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities. The Company is subject to taxation in the United States. All of the Companys tax years are subject to examination by Federal and state jurisdictions.   The Company classifies penalties and interest related to income taxes as income tax expense in the Statements of Operations. Basic Income (Loss) Per Share   Basic income (loss) per share is calculated by dividing the Companys net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the Companys net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There were no such common stock equivalents outstanding during the years ending October 31, 2015 and 2014.   Recent Accounting Pronouncements   The Company has reviewed all the recent accounting pronouncements issued to date of the issuance of these financial statements, and does not believe any of these pronouncements will have a material impact on the company. The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in United States of America and are presented in US dollars. The Company has adopted an October 31 fiscal year end. The Company is in the development stage as defined under the then current Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 915-205 Development-Stage Entities and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders deficit and cash flows disclosed activity since the date of its Inception (February 23, 2012) as a development stage company. Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.    The following are the hierarchical levels of inputs to measure fair value:    <table cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 45px; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"> </td> <td style="vertical-align: top; width: 45px; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify">Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.</td></tr> <tr> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"> </td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify">Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</td></tr> <tr> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"> </td> <td style="vertical-align: top; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"></td> <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify">Level 3 - Unobservable inputs reflecting the Companys assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</td></tr> </table>   The carrying amounts of the Companys financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.    The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.   The Company evaluates embedded conversion features within convertible debt under ASC 815 Derivatives and Hedging to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 Debt with Conversion and Other Options for consideration of any beneficial conversion feature.    The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.    For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.      Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.   The Company accounts for income taxes under the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 740, Accounting for Income Taxes. It prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As a result, the Company has applied a more-likely-than-not recognition threshold for all tax uncertainties. The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities. The Company is subject to taxation in the United States. All of the Companys tax years are subject to examination by Federal and state jurisdictions.   The Company classifies penalties and interest related to income taxes as income tax expense in the Statements of Operations. Basic income (loss) per share is calculated by dividing the Companys net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the Companys net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There were no such common stock equivalents outstanding during the years ending October 31, 2015 and 2014. The Company has reviewed all the recent accounting pronouncements issued to date of the issuance of these financial statements, and does not believe any of these pronouncements will have a material impact on the company.   Common Stock   The Company is authorized to issue 75,000,000 shares of common stock with a par value of $0.001 per share.   The Company had 10,300,000 shares of common stock issued and outstanding as of October 31, 2015.   Additional Paid in Capital   During the year ended October 31, 2015, the Company issued 37,500 stock purchase options for a value of $16,217, issued 600,000 stock purchase warrants for a value of $216,799.   Stock Subscription Payable   During the year ended October 31, 2015, the Company owed 35,294 of the Companys common stock as incentive to enter into a convertible note with a value of $11,881 and 110,000 shares of the Companys common stock as compensation for Thru Pharma related party expense valued at $38,400 for a total stock subscription payable of $50,281. Income taxes are accounted for under the assets and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled.   As of October 31, 2015, the Company had a net operating loss carry-forward of approximately $433,562 that may be used to offset future taxable income and begins to expire in 2031. Because of the change in ownership that occurred on January 16, 2014, net operating loss carry forwards could be limited as to use in future years.   This Amendment No. 1 corrects our previously issued financial statements for the year ended October 31, 2015, to record related party payable due to two consultants relating to consulting agreements to be paid with 7,500 options for the first consultant on a monthly basis convertible at $.80 per share entered into in February 2015 and the other to be paid in 10,000 common shares as stock payable. The Company issued 600,000 warrants on September 22, 2015 as payment for legal expenses that had not been recorded. The Company also entered into a convertible note agreement that previously had not been recorded that is considered a derivative or contains embedded features subject to derivative accounting related to a revolving convertible note where the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium totaling $37,500 which is added on 90 days after funding. The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881.   The effects of these corrections on the financial statements are as follows:    <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Arax Holdings Corp.</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Balance Sheets</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">October 31, 2015</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Reported</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Correction</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Restated</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 64%">Loans from related party</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">75,232</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">(37,550</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">37,682</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Convertible Notes payable, net of $43,188 debt discount</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">69,312</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">69,312</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Accrued Interest Payable</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,923</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,923</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Derivative Liability</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">5,500</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">5,500</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 1pt">Total current liabilities</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">75,232</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">39,185</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">114,417</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total liabilities</td> <td> </td> <td> </td> <td style="text-align: right">75,232</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">39,185</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">114,417</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Stock Subscription Payable</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">50,281</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">50,281</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Accumulated deficit</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(111,080</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(322,482</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(433,562</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 2.5pt">Total stockholders deficit</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(111,080</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(3,337</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(114,417</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>     <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Arax Holdings Corp.</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Statements of Operations</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Year Ended October 31, 2015</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Reported</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Correction</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Restated</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 64%; padding-bottom: 1pt">Professional Fees</td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">29,774</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">298,866</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid">$</td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">328,640</td> <td style="width: 1%; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">TOTAL OPERATING EXPENSES</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">29,774</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">298,866</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">328,640</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>NET LOSS FROM OPERATIONS</td> <td> </td> <td> </td> <td style="text-align: right">(29,774</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(298,866</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(328,640</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Interest Expense</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(18,116</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(18,116</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 1pt">Derivative Expense</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(25,434</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: right">(25,434</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Change in Fair Value of Derivative</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">19,934</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">19,934</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 1pt">TOTAL OTHER INCOME</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(23,616</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(23,616</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>NET LOSS BEFORE INCOME TAXES</td> <td> </td> <td> </td> <td style="text-align: right">(29,774</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(322,482</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(352,256</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 2.5pt">NET LOSS</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(29,774</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(322,482</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(352,256</td> <td style="padding-bottom: 2.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">NET LOSS PER SHARE: BASIC AND DILUTED</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.00</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.03</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.03</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>     <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="17" style="text-align: center">Arax Holdings Corp.</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="17" style="text-align: center">Statements of Changes in Stockholders Deficit</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="17" style="text-align: center">For the year ended October 31, 2015</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center"> </td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center">Additional Paid In</td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center">Stock Subscription</td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center">Accumulated</td> <td nowrap="nowrap"> </td> <td nowrap="nowrap"> </td> <td nowrap="nowrap" colspan="2" style="text-align: center">Total Stockholders</td> <td nowrap="nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-bottom: 1pt; text-decoration: underline">As Reported</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Capital</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Payable</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Deficit</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Deficit</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td nowrap="nowrap">Stock as Incentive for Convertible Note</td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap">Stock for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Options Granted for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants Issued for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 52%; padding-bottom: 1pt">Net loss for the period</td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right"></td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right"></td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">(29,774</td> <td style="width: 1%; padding-bottom: 1pt">)</td> <td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: black 1pt solid"> </td> <td style="width: 8%; border-bottom: black 1pt solid; text-align: right">(29,774</td> <td style="width: 1%; padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balances, October 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">25,548</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"></td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(111,080</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(75,232</td> <td style="padding-bottom: 2.5pt">)</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="text-decoration: underline">Correction</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock as Incentive for Convertible Note</td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">11,881</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">11,881</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Stock for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Options Granted for Compensation</td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Warrants Issued for Compensation</td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Net loss for the period</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(322,482</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(322,482</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 2.5pt">Balances, October 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">233,016</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">50,281</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(322,482</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(39,185</td> <td style="padding-bottom: 2.5pt">)</td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-decoration: underline">As Corrected</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Stock as Incentive for Convertible Note</td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">11,881</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">11,881</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock for Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Options Granted for Compensation</td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants Issued for Compensation</td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 1pt">Net loss for the period</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(352,256</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(352,256</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balances, October 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">258,564</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">50,281</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(433,562</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(114,417</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>     <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Arax Holdings Corp.</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Statements of Cash Flows</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center">Year Ended October 31, 2015</td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="text-align: center"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Reported</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">Correction</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td> <td nowrap="nowrap" colspan="2" style="border-bottom: black 1pt solid; text-align: center">As Restated</td> <td nowrap="nowrap" style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="width: 64%">Net loss for the period</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">(29,774</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">(322,482</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">(352,256</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock For Compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,400</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Derivative Liability addition</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">25,434</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">25,434</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Related party payable for services</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">27,450</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">27,450</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Options granted for compensation</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,217</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants issued for professional fees</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">216,799</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Change in Fair Value of Derivative</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(19,934</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(19,934</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Amortization of debt discount</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,193</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">16,193</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Accrued Interest Payable</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,923</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,923</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>NET CASH USED IN OPERATING ACTIVITIES</td> <td> </td> <td> </td> <td style="text-align: right">(29,774</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(29,774</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Proceeds from Convertible Note</td> <td> </td> <td> </td> <td style="text-align: right">29,774</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">29,774</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Proceeds from Convertible Note</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">65,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">65,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td>Payments to related party</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(65,000</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(65,000</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>NET CASH FLOWS FROM FINANCING ACTIVITIES</td> <td> </td> <td> </td> <td style="text-align: right">29,774</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">29,774</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 1pt">Original Issue Discount</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">10,000</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">10,000</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock as Incentive for Convertible Note</td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">11,881</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">11,881</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEECC"> <td style="padding-bottom: 2.5pt">TOTAL NON-CASH INVESTING AND FINANCING ACTIVITIES</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right"></td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">21,881</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">21,881</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   25434 0 25434 65000 0 65000 Denotes a loss of less than $(0.01) per share EX-101.SCH 7 fil-20151031.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 1. ORGANIZATION AND NATURE OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 2. GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 4. STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 5. RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 6. INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 7. COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 8. SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 9. CONVERTIBLE DEBT AND DERIVATIVE LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 10. FAIR VALUE MEASUREMENT link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 11. STOCK PURCHASE OPTIONS AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 10. FAIR VALUE MEASUREMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 11. STOCK PURCHASE OPTIONS AND WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Statement - 4. STOCKHOLDERS' DEFICIT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Statement - 5. RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Statement - 6. INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 10. FAIR VALUE MEASUREMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 11. STOCK PURCHASE OPTIONS AND WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 11. STOCK PURCHASE OPTIONS AND WARRANTS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 3) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 fil-20151031_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 fil-20151031_def.xml XBRL DEFINITION FILE EX-101.LAB 10 fil-20151031_lab.xml XBRL LABEL FILE Common Stock Shares Equity Components [Axis] Common Stock Additional Paid-in Capital Accumulated Deficit Total Stockholders' Deficit Principal shareholder and CEO Related Party [Axis] Thru Pharma Stock Subscription Payable Fair Value, Inputs, Level 1 [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Stock Option [Member] Award Type [Axis] Warrant [Member] As Reported [Member] Adjustments for Error Corrections [Axis] Correction [Member] Document and Entity Information: Entity Registrant Name Document Type Document Period End Date Amendment Flag Amendment Description Entity Central Index Key Current Fiscal Year End Date Entity Public Float Entity Common Stock, Shares Outstanding Entity Filer Category Entity Current Reporting Status Entity Voluntary Filers Entity Well-known Seasoned Issuer Document Fiscal Year Focus Document Fiscal Period Focus Assets [Abstract] Current Assets Total Current Assets Fixed Assets Equipment Total Fixed Assets Total Assets LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Loan from related party Convertible Notes payable, net of $41,797 debt discount Accrued Interest Payable Derivative Liability Total Current Liabilities Total Liabilities Commitments and Contingencies Stockholders' Deficit: Common stock, $0.001 par value; 75,000,000 shares authorized; 10,300,000 shares issued and outstanding Additional paid in capital Stock Subscription Payable Accumulated deficit Total Stockholders' Deficit Total Liabilities and Stockholders' Equity Discount on convertible note payable Common Stock, par value Common Stock, shares authorized Common Stock, shares issued Common Stock, shares Outstanding Income Statement [Abstract] REVENUES OPERATING EXPENSES Depreciation Expense Bank Service Charges Business Licenses and Permits Professional Fees Loss on Disposal of Fixed Assets TOTAL OPERATING EXPENSES NET LOSS FROM OPERATIONS Interest Expense Derivative expense Change in Fair Value of Derivative TOTAL OTHER INCOME NET LOSS BEFORE INCOME TAXES PROVISION FOR INCOME TAXES NET LOSS NET LOSS PER SHARE: BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED Statement [Table] Statement [Line Items] Beginning Balance, Shares Beginning Balance, Amount Stock as Incentive for Convertible Note Stock for compensation Options Granted for Compensation Warrants Issued for Compensation Derivative Liability Addition Forgiveness of related-party loan payable Net loss for the period Ending Balance, Shares Ending Balance, Amount Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss for the period Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Stock for Compensation Derivative Expense Related party payable for services Closing costs Options granted for compensation Warrants issued for professional fees Change in Fair Value of Derivative Amortization of debt discount Depreciation expense Loss on disposal of fixed assets Changes in operating assets and liabilities: Accrued Interest Payable NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES Equipment purchased NET CASH FLOWS FROM INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from sale of common stock Loan from related party Proceeds from convertible note Payments to related party NET CASH FLOWS FROM FINANCING ACTIVITIES NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS Cash, beginning of period Cash, end of period SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION Interest paid Income taxes paid SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Original Issue Discount Disposal of equipment without cash proceeds Forgiveness of loan from related party Total Noncash Investing and Financing Activities ORGANIZATION AND NATURE OF BUSINESS ORGANIZATION AND NATURE OF BUSINESS GOING CONCERN GOING CONCERN SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES COMMON STOCK STOCKHOLDERS' DEFICIT RELATED PARTY TRANSACTION RELATED PARTY TRANSACTIONS INCOME TAXES INCOME TAXES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES SUBSEQUENT EVENTS SUBSEQUENT EVENTS Convertible Debt And Derivative Liabilities CONVERTIBLE DEBT AND DERIVATIVE LIABILITIES Fair Value Measurement FAIR VALUE MEASUREMENT Stock Purchase Options And Warrants STOCK PURCHASE OPTIONS AND WARRANTS Restatement Of Financial Statements RESTATEMENT OF FINANCIAL STATEMENTS SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation Development Stage Company Use of Estimates Cash and Cash Equivalents Fair Value of Financial Instruments Embedded Conversion Features Debt Issue Costs and Debt Discount Original Issue Discount Income Taxes Revenue Recognition Advertising Basic Income (Loss) Per Share Recent Accounting Pronouncements Fair Value Measurement Tables Financial assets and (liabilities) carried at fair value measured on a recurring basis Stock Purchase Options And Warrants Tables Assumptions used to estimate the fair values of the stock warrants and options granted Summary of the changes in options outstanding Summary of the changes in warrants outstanding Restatement Of Financial Statements Tables Corrections on the interim consolidated financial statements COMMON STOCK TRANSACTIONS: Authorized to issue shares of common stock Shares of common stock with a par value per share Derivative Liability Addition Owed to related party INCOME TAX AS FOLLOWS Net operating loss carry-forward Operating Loss Carryforwards, Expiration Derivative Liability Expected stock price volatility, minimum Expected stock price volatility, maximum Expected stock price volatility Expected dividends Expected term Risk-free interest rate, minimum Risk-free interest rate, maximum Risk-free interest rate Number of Options Outstanding, Beginning Number of Options Granted Number of Options Exercised Number of Options expired or cancelled Number of Options Outstanding, Ending Weighted Average Exercise Price Outstanding, Beginning Weighted Average Exercise Price Granted Weighted Average Exercise Price Exercised Weighted Average Exercise Price expired or Canceled Weighted Average Exercise Price Outstanding, Ending Weighted Average Grant Date Fair Value Outstanding, Beginning Weighted Average Grant Date Fair Value Granted Weighted Average Grant Date Fair Value Exercised Weighted Average Grant Date Fair Value expired or Canceled Weighted Average Grant Date Fair Value Outstanding, Ending Expiration Date Outstanding, Beginning Expiration Date Granted Expiration Date Outstanding, Ending Value if Exercised Outstanding, Beginning Value if Exercised Granted Value if Exercised Outstanding, Ending Convertible Notes payable, net of $36,578 debt discount Total Current Liabilities Total Liabilities Total Stockholders' Deficit TOTAL OPERATING EXPENSES NET LOSS FROM OPERATIONS Derivative expense TOTAL OTHER INCOME NET LOSS BEFORE INCOME TAXES NET LOSS Ending Balance, Amount Stock for comepensation Derivative liability addition Related party payable receivable Net cash used in operating activities Proceeds from convertible note Net cash flows from financing activities The aggregate service charges related to banking services during the reporting period. Custom Element. Property, Plant and Equipment, Net Assets StockSubscriptionPayable Liabilities and Equity Gain (Loss) on Disposition of Assets Interest Expense Shares, Outstanding Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Increase (Decrease) in Accrued Liabilities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Proceeds from Related Party Debt Repayments of Related Party Debt Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, Fair Value Disclosure Cash and Cash Equivalents, at Carrying Value Nature of Operations [Text Block] Substantial Doubt about Going Concern [Text Block] Significant Accounting Policies [Text Block] Income Tax Disclosure [Text Block] Subsequent Events [Text Block] OriginalIssueDiscountPolicyTextBlock Derivative Liability [Default Label] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number NumberOfOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantDateFairValue ValueIfExercisedOutstanding ProceedsFromConvertibleNote EX-101.PRE 11 fil-20151031_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2

Document and Entity Information - USD ($)
12 Months Ended

Oct. 31, 2015

Feb. 12, 2016

Apr. 30, 2015

Document and Entity Information:

Entity Registrant Name Arax Holdings Corp

Document Type 10-K/A

Document Period End Date Oct. 31, 2015

Amendment Flag true

Amendment Description

The purpose of this Amendment No. 1 (the “Amendment”) to the registrant’s Annual Report on Form 10-K for the year ended October 31, 2015, filed with the Securities and Exchange Commission on February 16, 2016 (the “Annual Report”), is to record related party payables due to two consultants under consulting agreements with Thru Pharma to be paid with 7,500 options for the first consultant on a monthly basis convertible at $.80 per share entered into in February 2015 and the other to be paid in 10,000 common shares as stock payable, and record a management estimate of 25% of their overall compensation as a consulting expense. The Company issued 600,000 warrants on September 22, 2015 as payment for legal expenses that had not been recorded. The Company also entered into a convertible note agreement that previously had not been recorded that is considered a derivative or contains embedded features subject to derivative accounting related to a revolving convertible note in which the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium totaling $37,500 which is added on 90 days after funding. The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881.

No other changes have been made to the Annual Report except as noted above. This Amendment to the Annual Report speaks as of the original filing date of the Annual Report, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Annual Report except that changes have been made to the cover page, Note 9 – Convertible Debt and Derivative Liabilities, Note 10 - Fair Value Measurement, Note 11 – Stock Purchase Options and Warrants, and Note 12 – Correction of Financial Statements.

Entity Central Index Key 0001566243

Current Fiscal Year End Date --10-31

Entity Public Float $ 920,000

Entity Common Stock, Shares Outstanding 10,355,294

Entity Filer Category Smaller Reporting Company

Entity Current Reporting Status Yes

Entity Voluntary Filers No

Entity Well-known Seasoned Issuer No

Document Fiscal Year Focus 2015

Document Fiscal Period Focus FY

X

- Definition
Description of changes contained within amended document.
+ References
No definition available.
+ Details

Name: dei_AmendmentDescription

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_DocumentAndEntityInformationAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 13 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2

CONDENSED BALANCE SHEETS - USD ($)

Oct. 31, 2015

Oct. 31, 2014

Current Assets

Total Current Assets $ 0 $ 0

Fixed Assets

Total Assets 0 0

Current Liabilities

Loan from related party 37,682 45,458

Convertible Notes payable, net of $41,797 debt discount 69,312 0

Accrued Interest Payable 1,923 0

Derivative Liability 5,500 0

Total Current Liabilities 114,417 45,458

Total Liabilities 114,417 45,458

Commitments and Contingencies

Stockholders' Deficit:

Common stock, $0.001 par value; 75,000,000 shares authorized; 10,300,000 shares issued and outstanding 10,300 10,300

Additional paid in capital 258,564 25,548

Stock Subscription Payable 50,281 0

Accumulated deficit (433,562) (81,306)

Total Stockholders' Deficit (114,417) (45,458)

Total Liabilities and Stockholders' Equity $ 0 $ 0

X

- References
No definition available.
+ Details

Name: fil_StockSubscriptionPayable

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.30(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.18)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 12
-Article 7
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ConvertibleNotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13495-108611
+ Details

Name: us-gaap_DerivativeLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.32)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 25
-Article 7
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a)(5))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_NotesPayableRelatedPartiesClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 14 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)

Oct. 31, 2015

Oct. 31, 2014

Assets [Abstract]

Discount on convertible note payable $ 41,797 $ 0

Common Stock, par value $ 0.001 $ 0.001

Common Stock, shares authorized 75,000,000 75,000,000

Common Stock, shares issued 10,300,000 10,300,000

Common Stock, shares Outstanding 10,300,000 10,300,000

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The amount of debt discount (net of debt premium) that was originally recognized at the issuance of the instrument that has yet to be amortized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28567-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399
+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2

CONDENSED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended

Oct. 31, 2015

Oct. 31, 2014

Income Statement [Abstract]

REVENUES $ 0 $ 0

OPERATING EXPENSES

Depreciation Expense 0 29

Bank Service Charges 0 24

Professional Fees 328,640 49,813

Loss on Disposal of Fixed Assets 0 428

TOTAL OPERATING EXPENSES 328,640 50,294

NET LOSS FROM OPERATIONS (328,640) (50,294)

Interest Expense (18,116) 0

Derivative expense (25,434) 0

Change in Fair Value of Derivative 19,934 0

TOTAL OTHER INCOME (23,616) 0

NET LOSS BEFORE INCOME TAXES (352,256) (50,294)

PROVISION FOR INCOME TAXES 0 0

NET LOSS $ (352,256) $ (50,294)

NET LOSS PER SHARE: BASIC AND DILUTED $ (.03) $ (0.00) ^[1]

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED 10,300,000 10,300,000

[1] Denotes a loss of less than $(0.01) per share

X

- Definition
The aggregate service charges related to banking services during the reporting period.
+ References
No definition available.
+ Details

Name: fil_BankServiceCharges

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of unrealized gain (loss) recognized in the income statement for a financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=51824106&loc=d3e2443-110228
+ Details

Name: us-gaap_GainLossOnDispositionOfAssets1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Interest expense incurred on short positions arising from sales of securities and other assets, which the entity does not own, to other parties. Trading liabilities includes the fair value of derivative contracts held for trading that are in loss positions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.7)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpenseTradingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.4)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_OtherIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07.2(a),(b),(c),(d))
-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 225
-Section 45
-Paragraph 3
-Subparagraph (k)
-URI http://asc.fasb.org/extlink&oid=6488370&loc=d3e13550-115849
+ Details

Name: us-gaap_ProfessionalFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)

Common Stock

Additional Paid-in Capital

Stock Subscription Payable

Accumulated Deficit

Total Stockholders' Deficit

Beginning Balance, Shares at Oct. 31, 2013 10,300,000

Beginning Balance, Amount at Oct. 31, 2013 $ 10,300 $ 20,700 $ (31,012) $ (12)

Forgiveness of related-party loan payable 4,848 4,848

Net loss for the period (50,294) (50,294)

Ending Balance, Shares at Oct. 31, 2014 10,300,000

Ending Balance, Amount at Oct. 31, 2014 $ 10,300 25,548 (81,306) (45,458)

Stock as Incentive for Convertible Note 0 $ 11,881 0 11,881

Stock for compensation 38,400 38,400

Options Granted for Compensation 16,217 0 0 16,217

Warrants Issued for Compensation 216,799 0 0 216,799

Net loss for the period 0 0 (352,256) (352,256)

Ending Balance, Shares at Oct. 31, 2015 10,300,000

Ending Balance, Amount at Oct. 31, 2015 $ 10,300 $ 258,564 $ 50,281 $ (433,562) $ (114,417)

X

- References
No definition available.
+ Details

Name: fil_OptionsGrantedForCompensation

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_StockAsIncentiveForConvertibleNote

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_WarrantsIssuedForCompensation

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_DebtInstrumentDecreaseForgiveness

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Value, after forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 30
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51830203&loc=d3e3913-113898

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 30
-Section 35
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418191&loc=d3e15009-113911
+ Details

Name: us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=fil_StockSubscriptionPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended

Oct. 31, 2015

Oct. 31, 2014

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss for the period $ (361,103) $ (50,294)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

Stock for Compensation 38,400 0

Derivative Expense 25,434 0

Related party payable for services 27,450

Options granted for compensation 16,217 0

Warrants issued for professional fees 216,799 0

Change in Fair Value of Derivative (19,934) 0

Amortization of debt discount 16,193 0

Depreciation expense 0 29

Loss on disposal of fixed assets 0 428

Changes in operating assets and liabilities:

Accrued Interest Payable 1,923 0

NET CASH USED IN OPERATING ACTIVITIES (29,774) (49,837)

CASH FLOWS FROM INVESTING ACTIVITIES

NET CASH FLOWS FROM INVESTING ACTIVITIES 0 0

CASH FLOWS FROM FINANCING ACTIVITIES

Loan from related party 29,774 46,085

Proceeds from convertible note 65,000 0

Payments to related party (65,000) 0

NET CASH FLOWS FROM FINANCING ACTIVITIES 29,774 46,085

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS 0 (3,752)

Cash, beginning of period 0 3,752

Cash, end of period 0 0

SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION

Interest paid 0 0

Income taxes paid 0 0

SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES

Original Issue Discount 10,000 0

Stock as Incentive for Convertible Note 11,881

Disposal of equipment without cash proceeds 0 428

Forgiveness of loan from related party 0 4,848

Total Noncash Investing and Financing Activities $ 21,881 $ 5,276

X

- References
No definition available.
+ Details

Name: fil_DisposalOfEquipmentWithoutCashProceeds

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_OptionsGrantedForCompensation

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_OriginalInterestDiscount

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_StockAsIncentiveForConvertibleNote

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_TotalNoncashInvestingAndFinancingActivities

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_WarrantsIssuedForCompensation

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016
+ Details

Name: us-gaap_CashAndCashEquivalentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_DebtInstrumentDecreaseForgiveness

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationNonproduction

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of unrealized gain (loss) recognized in the income statement for a financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2941-110230
+ Details

Name: us-gaap_GainLossOnDispositionOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585
+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Interest expense incurred on short positions arising from sales of securities and other assets, which the entity does not own, to other parties. Trading liabilities includes the fair value of derivative contracts held for trading that are in loss positions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.7)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpenseTradingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585
+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromConvertibleDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_RepaymentsOfRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value, after forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 30
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51830203&loc=d3e3913-113898

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 30
-Section 35
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418191&loc=d3e15009-113911
+ Details

Name: us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 18 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2

1. ORGANIZATION AND NATURE OF BUSINESS
12 Months Ended

Oct. 31, 2015

ORGANIZATION AND NATURE OF BUSINESS

ORGANIZATION AND NATURE OF BUSINESS
Arax Holdings Corp. (the “Company”, “we”, “our” or “us”) was incorporated under the laws of the State of Nevada on February 23, 2012 with a business plan to sell hot dogs from mobile hot dog stands throughout the major cities in Mexico. As of the filing of the 10K for last year, the Company stated that it was re-evaluating its business plan.

It was further indicated as possible that a new business model could be related to a new business sector other than the food sector, and that any new business model could entail a capital restructuring of the Company in order to provide new capital and a broader base of shareholders. Such a capital restructuring of the Company could involve a merger or acquisition of assets through various techniques, including a possible reverse-merger. At October 31, 2015, and as of the date of this filing, Management believes that the best business model for our investors is to pursue business activity in the Life Sciences sector of the United States and possibly internationally. We will continue to assess these opportunities and structures as well as the various pre-requisite actions needed to finalize and implement any new business model.

The Company is a majority-owned subsidiary of Thru Pharma, LLC, and these financials are presented on a stand-alone basis. All transactions with Thru Pharma have been identified in Note 4: Stockholders’ deficit and Note 5: Related party transactions.

Pursuant to a revision to a certain Consulting Agreement dated as of October 8, 2013, by and between Thru Pharma and Strategic Universal Advisors, LLC (“Strategic”), as amended effective January 17, 2014, on or about February 9, 2015, and most recently on October 20, 2015, with full effect as of April 1, 2015 (the “Consulting Agreement”), Thru Pharma and Strategic agreed that the intent of the Consulting Agreement ab initio was to provide Strategic with a 3% equity ownership of Thru Pharma n the event that a PUBCO M&A transaction di not occur prior to the end of the Consulting Agreement. Thru Pharma and Strategic agreed and stipulated that 753,504 shares of Arax Holdings would equal 3% of Thru Pharma as the equity payment under the Consulting Agreement, with transfer subject to the further provisions stated below. As Thru Pharma was the sole beneficiary of the services provided by Strategic under the Consulting Agreement, no part of the value of the consideration for services provided under the Consulting Agreement has been recognized as an expense by the Company.

In connection with earlier amendments to the Consulting Agreement, Strategic granted to Mr. Keough, a control person of the Company and Thru Pharma, an irrevocable proxy (the “Irrevocable Proxy”), to vote all of the common stock in the Company under certain conditions. That proxy no longer exists under the terms of the most recent amendment.

As part of the currently amended Consulting Agreement, Thru Pharma agreed to transfer 753,504 Company shares to Strategic upon the closing of a merger or acquisition (an “M&A Transaction”) of a public entity, resulting in Thru Pharma being the controlling owner of the entity that was the subject of the M&A Transaction, and Thru Pharma would cause such entity to also issue to Strategic a stock warrant to purchase 600,000 (six hundred thousand) shares of common stock of the entity that was the subject of the M&A Transaction. Such warrant will be of five-year duration, exercisable at $0.10 per share, and shall vest in four equal amounts of 150,000 shares with the first annual vesting to occur 60 (sixty) days following the completion of the PUBCO M&A Transaction, as well as other routine terms.

Notwithstanding anything to the contrary provided in the Consulting Agreement or elsewhere, in no event would Thru Pharma be directly and/or indirectly obligated to enter into or complete any particular M&A Transaction, including, but not limited to, any M&A Transaction with the Company.

Effective July 1, 2015, Arax and Catalyst Funding, LLC, entered into an Original Issue Discount Revolving Secured Convertible Promissory Note (the “Catalyst Note”) and a Securities Purchase Agreement (the “Catalyst SPA”). The transaction is secured by a grant of security interest to 100% of the Company stock held by or for Thru Pharma. The Catalyst Note and Catalyst SPA are intended to facilitate funding essential work relating to multi-year auditing of Thru Pharma financials. The total potentially available funds are $200,000, and the Company has only drawn $75,000, and for which the Company is the obligor. A Commitment Fee of Company stock in the amount of 35,294 shares was authorized for issue to Catalyst as part of the transaction. In the event that the Company is unable to timely make payments under this Agreement, Catalyst has the option of gaining control of the Thru Pharma shares in the Company.

The Company’s status as a “shell company” as of the date of this report remains unchanged.

X

- References
No definition available.
+ Details

Name: fil_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract1

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6003-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 2A
-URI http://asc.fasb.org/extlink&oid=51801978&loc=SL51803626-108592
+ Details

Name: us-gaap_NatureOfOperations

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2

2. GOING CONCERN
12 Months Ended

Oct. 31, 2015

GOING CONCERN

GOING CONCERN
The accompanying financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern. However, the Company has not generated any revenues as of October 31, 2015. The Company has incurred losses since Inception (February 23, 2012) resulting in an accumulated deficit of $433,562 as of October 31, 2015 and further losses are anticipated in the development of its business. The Company currently has no cash balance, a working capital deficit and stockholders’ deficit of $114,417 and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time.

The Company is dependent on additional investment capital to fund operating expenses. The Company intends to position itself so that it can be able to raise additional funds through the capital markets. In light of management’s efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

X

- References
No definition available.
+ Details

Name: fil_GoingConcernAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 40
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51888302&loc=SL51888449-203568

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 40
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51888302&loc=SL51888443-203568
+ Details

Name: us-gaap_SubstantialDoubtAboutGoingConcernTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended

Oct. 31, 2015

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in United States of America and are presented in US dollars. The Company has adopted an October 31 fiscal year end.

Development Stage Company

The Company is in the development stage as defined under the then current Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 915-205 “Development-Stage Entities” and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders’ deficit and cash flows disclosed activity since the date of its Inception (February 23, 2012) as a development stage company. Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents.

Fair Value of Financial Instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

• Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

• Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

• Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.

Embedded Conversion Features

The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature.

Debt Issue Costs and Debt Discount

The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.

Original Issue Discount

For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.

Income Taxes

Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.

The Company accounts for income taxes under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740, “Accounting for Income Taxes”. It prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As a result, the Company has applied a more-likely-than-not recognition threshold for all tax uncertainties. The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities. The Company is subject to taxation in the United States. All of the Company’s tax years are subject to examination by Federal and state jurisdictions.

The Company classifies penalties and interest related to income taxes as income tax expense in the Statements of Operations.

Basic Income (Loss) Per Share

Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the Company’s net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There were no such common stock equivalents outstanding during the years ending October 31, 2015 and 2014.

Recent Accounting Pronouncements

The Company has reviewed all the recent accounting pronouncements issued to date of the issuance of these financial statements, and does not believe any of these pronouncements will have a material impact on the company.

X

- References
No definition available.
+ Details

Name: fil_AccountingPoliciesAbstract1

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18854-107790
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2

4. STOCKHOLDERS' DEFICIT
12 Months Ended

Oct. 31, 2015

COMMON STOCK

STOCKHOLDERS' DEFICIT
Common Stock

The Company is authorized to issue 75,000,000 shares of common stock with a par value of $0.001 per share.

The Company had 10,300,000 shares of common stock issued and outstanding as of October 31, 2015.

Additional Paid in Capital

During the year ended October 31, 2015, the Company issued 37,500 stock purchase options for a value of $16,217, issued 600,000 stock purchase warrants for a value of $216,799.

Stock Subscription Payable

During the year ended October 31, 2015, the Company owed 35,294 of the Company’s common stock as incentive to enter into a convertible note with a value of $11,881 and 110,000 shares of the Company’s common stock as compensation for Thru Pharma related party expense valued at $38,400 for a total stock subscription payable of $50,281.

X

- References
No definition available.
+ Details

Name: fil_EquityAbstract1

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2

5. RELATED PARTY TRANSACTIONS
12 Months Ended

Oct. 31, 2015

RELATED PARTY TRANSACTION

RELATED PARTY TRANSACTIONS
In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders or directors. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note.

The Company owed its majority shareholder, Thru Pharma, a total of $37,682 as of October 31, 2015, in the form of a related party payable. It is due on demand and is non-interest bearing.

X

- References
No definition available.
+ Details

Name: fil_RelatedPartyDisclosuresAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph b
-Article 3A
+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2

6. INCOME TAXES
12 Months Ended

Oct. 31, 2015

INCOME TAXES

INCOME TAXES
Income taxes are accounted for under the assets and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled.

As of October 31, 2015, the Company had a net operating loss carry-forward of approximately $433,562 that may be used to offset future taxable income and begins to expire in 2031. Because of the change in ownership that occurred on January 16, 2014, net operating loss carry forwards could be limited as to use in future years.

X

- References
No definition available.
+ Details

Name: fil_IncomeTaxesAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2

7. COMMITMENTS AND CONTINGENCIES
12 Months Ended

Oct. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES
Legal

On June 4, 2014, we were named as a defendant in a lawsuit filed by AMERIFINANCIAL, INC. (“AMERIFINANCIAL”), of Houston, Texas. The action related primarily to a contract dispute between AMERIFINANCIAL and our majority shareholder, Thru Pharma, LLC. The dispute did not allege any actions or inactions by our officers or representatives acting on our behalf. Counsel for Thru Pharma, LLC, requested that we be dismissed from this lawsuit, as we were not party to the disputed contract, and there was no legal basis for the Company being a part of the lawsuit. Accordingly, the Company did not recognize a liability in connection with the suit.

On August 31, 2015, the Judge in this Harris County, Texas, case ruled that the only remaining Defendant was Thru Pharma, LLC. Subsequent to our year end, on January 8, 2016, Thru Pharma and AMERIFINANCIAL, INC. reached settlement of the dispute.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2

8. SUBSEQUENT EVENTS
12 Months Ended

Oct. 31, 2015

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS
In accordance with ASC 855-10, “Subsequent Events” the Company has analyzed its operations subsequent to October 31, 2015 to the date these financial statements were issued. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881.

X

- References
No definition available.
+ Details

Name: fil_SubsequentEventsAbstract1

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2

9. CONVERTIBLE DEBT AND DERIVATIVE LIABILITIES
12 Months Ended

Oct. 31, 2015

Convertible Debt And Derivative Liabilities

CONVERTIBLE DEBT AND DERIVATIVE LIABILITIES
The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting related to a revolving convertible note in which the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium which is added on 90 days after funding. The note is to be paid off in installments of $19,453 for six months after the ninety day period. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has estimated the fair value of these embedded derivatives for convertible debentures using a multinomial lattice model as of July 31, 2015 and October 31, 2015.

The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%.

X

- References
No definition available.
+ Details

Name: fil_ConvertibleDebtAndDerivativeLiabilitiesAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20,22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2

10. FAIR VALUE MEASUREMENT
12 Months Ended

Oct. 31, 2015

Fair Value Measurement

FAIR VALUE MEASUREMENT
The Company uses the multinomial lattice model to calculate the fair value of the derivative liability.

Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of October 31, 2015 and 2014 consisted of the following:

Fair Value Measurements Using

Description Total Fair
Value at
October 31,
2015 Quoted
Prices in
Active
Markets
(Level 1) Significant
Other
Observable
Inputs
(Level 2) Significant
Unobservable
Inputs
(Level 3)

Derivative liability $ 5,500 $ — $ 5,500 $ —

Fair Value Measurements Using

Description Total Fair
Value at
October 31,
2014 Quoted
Prices in
Active
Markets
(Level 1) Significant
Other
Observable
Inputs
(Level 2) Significant
Unobservable
Inputs
(Level 3)

None $ — $ — $ — $ —

X

- References
No definition available.
+ Details

Name: fil_FairValueMeasurementAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611
+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2

11. STOCK PURCHASE OPTIONS AND WARRANTS
12 Months Ended

Oct. 31, 2015

Stock Purchase Options And Warrants

STOCK PURCHASE OPTIONS AND WARRANTS
During the year ended October 31, 2015, the Company issued options to purchase a total of 37,500 shares of the Company’s Common Stock. The Company issued 37,500 options in conjunction with a consulting agreement entered into in February 2015. According to the consulting agreement, the company is to issue either 5,000 common shares or 7,500 options per month during the duration of their agreements. The options were valued using the multinomial lattice pricing model under the assumptions noted below.

Stock Purchase Options

During the year ended October 31, 2015, the Company issued 37,500 stock purchase options for a value of $16,217.

During the year ended October 31, 2014, the Company did not issue any stock purchase options.

The following table presents the assumptions used to estimate the fair values of the stock warrants and options granted:

2015 2014

Expected volatility 202-213 % N/A

Expected dividends 0 % N/A

Expected term 3 Years N/A

Risk-free interest rate 0.80-1.09 % N/A

F-12

The following table summarizes the changes in options outstanding of the Company during the year ended October 31, 2015.

Date Issued Number
of
Options Weighted
Average
Exercise
Price Weighted
Average
Grant Date
Fair Value Expiration
Date (yrs) Value if
Exercised

Balance as of October 31, 2014 — $ — $ — — $ —

Granted 37,500 0.80 0.41 2.64 30,000

Exercised — — — — —

Cancelled/Expired — — — — —

Outstanding as of October 31, 2015 37,500 $ 0.80 $ 0.41 2.47 $ 30,000

Stock Purchase Warrants

During the year ended October 31, 2015, the Company issued warrants to purchase a total of 600,000. The Company issued 600,000 warrants in conjunction with a consulting agreement entered into in July 2015. The warrants were valued using the multinomial lattice pricing model under the assumptions noted below.

During the year ended October 31, 2015, the Company issued 600,000 stock purchase warrants for a value of $216,799.

During the year ended October 31, 2014, the Company did not issue any stock purchase warrants.

The following table presents the assumptions used to estimate the fair values of the stock warrants and options granted:

2015 2014

Expected volatility 212 % N/A

Expected dividends 0 % N/A

Expected term 3 Years N/A

Risk-free interest rate 1.08 % N/A

The following table summarizes the changes in warrants outstanding issued to employees and non-employees of the Company during the year ended October 31, 2015.

Number
of
Warrants Weighted
Average
Exercise
Price Weighted
Average
Grant Date
Fair Value Expiration
Date (yrs) Value if
Exercised

Outstanding as of October 31, 2014 — $ — $ — — $ —

Granted 600,000 0.80 0.36 2.73 480,000

Exercised — — — — —

Cancelled/Expired — — — — —

Outstanding as of October 31, 2015 600,000 $ 0.80 $ 0.36 2.73 $ 480,000

X

- References
No definition available.
+ Details

Name: fil_StockPurchaseOptionsAndWarrantsAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_StockPurchaseOptionsAndWarrantsTextBlock

Namespace Prefix: fil_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2

12. RESTATEMENT OF FINANCIAL STATEMENTS
12 Months Ended

Oct. 31, 2015

Restatement Of Financial Statements

RESTATEMENT OF FINANCIAL STATEMENTS
This Amendment No. 1 corrects our previously issued financial statements for the year ended October 31, 2015, to record related party payable due to two consultants relating to consulting agreements to be paid with 7,500 options for the first consultant on a monthly basis convertible at $.80 per share entered into in February 2015 and the other to be paid in 10,000 common shares as stock payable. The Company issued 600,000 warrants on September 22, 2015 as payment for legal expenses that had not been recorded. The Company also entered into a convertible note agreement that previously had not been recorded that is considered a derivative or contains embedded features subject to derivative accounting related to a revolving convertible note where the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium totaling $37,500 which is added on 90 days after funding. The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881.

The effects of these corrections on the financial statements are as follows:

Arax Holdings Corp.

Balance Sheets

October 31, 2015

As Reported Correction As Restated

Loans from related party $ 75,232 $ (37,550 ) $ 37,682

Convertible Notes payable, net of $43,188 debt discount — 69,312 69,312

Accrued Interest Payable — 1,923 1,923

Derivative Liability — 5,500 5,500

Total current liabilities 75,232 39,185 114,417

Total liabilities 75,232 39,185 114,417

Stock Subscription Payable — 50,281 50,281

Accumulated deficit (111,080 ) (322,482 ) (433,562 )

Total stockholders’ deficit $ (111,080 ) $ (3,337 ) $ (114,417 )

Arax Holdings Corp.

Statements of Operations

Year Ended October 31, 2015

As Reported Correction As Restated

Professional Fees $ 29,774 $ 298,866 $ 328,640

TOTAL OPERATING EXPENSES 29,774 298,866 328,640

NET LOSS FROM OPERATIONS (29,774 ) (298,866 ) (328,640 )

Interest Expense — (18,116 ) (18,116 )

Derivative Expense — (25,434 ) (25,434 )

Change in Fair Value of Derivative — 19,934 19,934

TOTAL OTHER INCOME — (23,616 ) (23,616 )

NET LOSS BEFORE INCOME TAXES (29,774 ) (322,482 ) (352,256 )

NET LOSS (29,774 ) (322,482 ) (352,256 )

NET LOSS PER SHARE: BASIC AND DILUTED $ (0.00 ) $ (0.03 ) $ (0.03 )

Arax Holdings Corp.

Statements of Changes in Stockholders’ Deficit

For the year ended October 31, 2015

Additional
Paid In Stock
Subscription Accumulated Total
Stockholders’

As Reported Capital Payable Deficit Deficit

Stock as Incentive for Convertible Note $ — $ — $ — $ —

Stock for Compensation — — — —

Options Granted for Compensation — — — —

Warrants Issued for Compensation — — — —

Net loss for the period — — (29,774 ) (29,774 )

Balances, October 31, 2015 $ 25,548 — $ (111,080 ) $ (75,232 )

Correction

Stock as Incentive for Convertible Note $ — $ 11,881 $ — $ 11,881

Stock for Compensation — 38,400 — 38,400

Options Granted for Compensation 16,217 — — 16,217

Warrants Issued for Compensation 216,799 — — 216,799

Net loss for the period — — (322,482 ) (322,482 )

Balances, October 31, 2015 $ 233,016 $ 50,281 $ (322,482 ) $ (39,185 )

As Corrected

Stock as Incentive for Convertible Note $ — $ 11,881 $ — $ 11,881

Stock for Compensation — 38,400 — 38,400

Options Granted for Compensation 16,217 — — 16,217

Warrants Issued for Compensation 216,799 — — 216,799

Net loss for the period — — (352,256 ) (352,256 )

Balances, October 31, 2015 $ 258,564 $ 50,281 $ (433,562 ) $ (114,417 )

Arax Holdings Corp.

Statements of Cash Flows

Year Ended October 31, 2015

As Reported Correction As Restated

Net loss for the period $ (29,774 ) $ (322,482 ) $ (352,256 )

Stock For Compensation — 38,400 38,400

Derivative Liability addition — 25,434 25,434

Related party payable for services — 27,450 27,450

Options granted for compensation — 16,217 16,217

Warrants issued for professional fees — 216,799 216,799

Change in Fair Value of Derivative — (19,934 ) (19,934 )

Amortization of debt discount — 16,193 16,193

Accrued Interest Payable — 1,923 1,923

NET CASH USED IN OPERATING ACTIVITIES (29,774 ) — (29,774 )

Proceeds from Convertible Note 29,774 — 29,774

Proceeds from Convertible Note — 65,000 65,000

Payments to related party — (65,000 ) (65,000 )

NET CASH FLOWS FROM FINANCING ACTIVITIES 29,774 — 29,774

Original Issue Discount $ — $ 10,000 $ 10,000

Stock as Incentive for Convertible Note $ — $ 11,881 $ 11,881

TOTAL NON-CASH INVESTING AND FINANCING ACTIVITIES $ — $ 21,881 $ 21,881

X

- References
No definition available.
+ Details

Name: fil_CorrectionOfInterimCondensedFinancialStatementsAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22644-107794

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=6368906&loc=d3e21914-107793

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22595-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 1.N.Q3)
-URI http://asc.fasb.org/extlink&oid=26874127&loc=d3e30840-122693

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 1
-Section N
+ Details

Name: us-gaap_AccountingChangesAndErrorCorrectionsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2

3. SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended

Oct. 31, 2015

SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation
The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in United States of America and are presented in US dollars. The Company has adopted an October 31 fiscal year end.

Development Stage Company
The Company is in the development stage as defined under the then current Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 915-205 “Development-Stage Entities” and among the additional disclosures required as a development stage company are that its financial statements were identified as those of a development stage company, and that the statements of operations, stockholders’ deficit and cash flows disclosed activity since the date of its Inception (February 23, 2012) as a development stage company. Effective June 10, 2014 FASB changed its regulations with respect to Development Stage Entities and these additional disclosures are no longer required.

Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents
The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents.

Fair Value of Financial Instruments
The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

• Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

• Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

• Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 2.

Embedded Conversion Features
The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature.

Debt Issue Costs and Debt Discount
The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.

Original Issue Discount
For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.

Income Taxes

Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.

The Company accounts for income taxes under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740, “Accounting for Income Taxes”. It prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As a result, the Company has applied a more-likely-than-not recognition threshold for all tax uncertainties. The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities. The Company is subject to taxation in the United States. All of the Company’s tax years are subject to examination by Federal and state jurisdictions.

The Company classifies penalties and interest related to income taxes as income tax expense in the Statements of Operations.

Basic Income (Loss) Per Share
Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the Company’s net loss available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There were no such common stock equivalents outstanding during the years ending October 31, 2015 and 2014.

Recent Accounting Pronouncements
The Company has reviewed all the recent accounting pronouncements issued to date of the issuance of these financial statements, and does not believe any of these pronouncements will have a material impact on the company.

X

- References
No definition available.
+ Details

Name: fil_DebtIssueCostsAndDebtDiscountPolicyTextBlock

Namespace Prefix: fil_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_DevelopmentStageCompanyDisclosure

Namespace Prefix: fil_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_EmbeddedConversionFeaturesPolicyTextBlock

Namespace Prefix: fil_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_OriginalIssueDiscountPolicyTextBlock

Namespace Prefix: fil_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_SignificantAccountingPoliciesAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 305
-SubTopic 10
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Financial Reporting Release (FRR)
-Number 203
-Paragraph 02-03

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 1
-Article 5
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32840-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6423966&loc=d3e40913-109327

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32247-109318

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32280-109318
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2

10. FAIR VALUE MEASUREMENT (Tables)
12 Months Ended

Oct. 31, 2015

Fair Value Measurement Tables

Financial assets and (liabilities) carried at fair value measured on a recurring basis

Fair Value Measurements Using

Description Total Fair
Value at
October 31,
2015 Quoted
Prices in
Active
Markets
(Level 1) Significant
Other
Observable
Inputs
(Level 2) Significant
Unobservable
Inputs
(Level 3)

Derivative liability $ 5,500 $ — $ 5,500 $ —

Fair Value Measurements Using

Description Total Fair
Value at
October 31,
2014 Quoted
Prices in
Active
Markets
(Level 1) Significant
Other
Observable
Inputs
(Level 2) Significant
Unobservable
Inputs
(Level 3)

None $ — $ — $ — $ —

X

- References
No definition available.
+ Details

Name: fil_FairValueMeasurementTablesAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19279-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a,b,bb)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2C
-URI http://asc.fasb.org/extlink&oid=36462937&loc=SL7498348-110258

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258
+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2

11. STOCK PURCHASE OPTIONS AND WARRANTS (Tables)
12 Months Ended

Oct. 31, 2015

Stock Purchase Options And Warrants Tables

Assumptions used to estimate the fair values of the stock warrants and options granted

2015 2014

Expected volatility 202-213% N/A

Expected dividends 0 % N/A

Expected term 3 Years N/A

Risk-free interest rate 0.80-1.09% N/A



2015 2014

Expected volatility 212 % N/A

Expected dividends 0 % N/A

Expected term 3 Years N/A

Risk-free interest rate 1.08 % N/A

Summary of the changes in options outstanding

Date Issued Number
of
Options Weighted
Average
Exercise
Price Weighted
Average
Grant Date
Fair Value Expiration
Date (yrs) Value if
Exercised

Balance as of October 31, 2014 — $ — $ — — $ —

Granted 37,500 0.80 0.41 2.64 30,000

Exercised — — — — —

Cancelled/Expired — — — — —

Outstanding as of October 31, 2015 37,500 $ 0.80 $ 0.41 2.47 $ 30,000

Summary of the changes in warrants outstanding

Number
of
Warrants Weighted
Average
Exercise
Price Weighted
Average
Grant Date
Fair Value Expiration
Date (yrs) Value if
Exercised

Outstanding as of October 31, 2014 — $ — $ — — $ —

Granted 600,000 0.80 0.36 2.73 480,000

Exercised — — — — —

Cancelled/Expired — — — — —

Outstanding as of October 31, 2015 600,000 $ 0.80 $ 0.36 2.73 $ 480,000

X

- References
No definition available.
+ Details

Name: fil_StockPurchaseOptionsAndWarrantsTablesAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the assumptions used to determine for pension plans and/or other employee benefit plans the benefit obligation and net benefit cost, including assumed discount rates, rate increase in compensation increase, and expected long-term rates of return on plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (k)
-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920
+ Details

Name: us-gaap_ScheduleOfAssumptionsUsedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 28
-Article 5
+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2

12. RESTATEMENT OF FINANCIAL STATEMENTS (Tables)
12 Months Ended

Oct. 31, 2015

Restatement Of Financial Statements Tables

Corrections on the interim consolidated financial statements

Arax Holdings Corp.

Balance Sheets

October 31, 2015

As Reported Correction As Restated

Loans from related party 75,232 (37,550 ) 37,682

Convertible Notes payable, net of $36,578 debt discount — 75,922 75,922

Accrued Interst Payable — 1,923 1,923

Derivative Liability — 5,500 5,500

Total current liabilities 75,232 45,795 121,027

Total liabilities 75,232 45,795 121,027

Stock Subscription Payable — 52,518 52,518

Accumulated deficit (111,080 ) (331,329 ) (442,409 )

Total stockholders’ deficit (111,080 ) (9,947 ) (121,027 )

Arax Holdings Corp.

Statements of Operations

Year Ended October 31, 2015

As Reported Correction As Restated

Professional Fees 29,774 298,866 328,640

TOTAL OPERATING EXPENSES 29,774 298,866 328,640

NET LOSS FROM OPERATIONS (29,774 ) (298,866 ) (328,640 )

Interest Expense — (26,963 ) (26,963 )

Derivative Expense — (25,434 ) (25,434 )

Change in Fair Value of Derivative — 19,934 19,934

TOTAL OTHER INCOME — (32,463 ) (32,463 )

NET LOSS BEFORE INCOME TAXES (29,774 ) (331,329 ) (361,103 )

NET LOSS (29,774 ) (331,329 ) (361,103 )

NET LOSS PER SHARE: BASIC AND DILUTED $ (0.00 ) $ (0.04 ) $ (0.04 )

Arax Holdings Corp

Statements of Changes in Stockholders’ Deficit

Additional
Paid In Stock
Subscription Accumulated Total
Stockholders’

As Reported Capital Payable Deficit Deficit

Stock as Incentive for Convertible Note — — — —

Stock for Compensation — — — —

Options Granted for Compensation — — — —

Warrants Issued for Compensation — — — —

Net loss for the period — — (29,774 ) (29,774 )

Balances, October 31, 2015 $ 25,548 — ($ 111,080 ) ($ 75,232 )

Correction

Stock as Incentive for Convertible Note — 14,118 — 14,118

Stock for Compensation — 38,400 — 38,400

Options Granted for Compensation 16,217 — — 16,217

Warrants Issued for Compensation 216,799 — — 216,799

Net loss for the period — — (331,329 ) (331,329 )

Balances, October 31, 2015 $ 233,016 $ 52,518 ($ 331,329 ) ($ 45,795 )

As Corrected

Stock as Incentive for Convertible Note — 14,118 — 14,118

Stock for Compensation — 38,400 — 38,400

Options Granted for Compensation 16,217 — — 16,217

Warrants Issued for Compensation 216,799 — — 216,799

Net loss for the period — — (361,103 ) (361,103 )

Balances, October 31, 2015 $ 258,564 $ 52,518 ($ 442,409 ) ($ 121,027 )

Arax Holdings Corp.

Statements of Cash Flows

Year Ended October 31, 2015

As Reported Correction As Restated

Net loss for the period $ (29,774 ) $ (331,329 ) $ (361,103 )

Stock For Compensation — 38,400 38,400

Stock as Incentive for Convertible Note — 14,118 14,118

Derivative Liability addition — 25,434 25,434

Options granted for compensation — 16,217 16,217

Warrants issued for professional fees — 216,799 216,799

Change in Fair Value of Derivative — (19,934 ) (19,934 )

Amortization of debt discount — 10,922 10,922

Accrued Interest Payable — 1,923 1,923

Proceeds from Convertible Note — 65,000 65,000

Payments to related party — (65,000 ) (65,000 )

Original Issue Discount $ — $ 10,000 $ 10,000

TOTAL NON-CASH INVESTING AND FINANCING ACTIVITIES $ — $ 10,000 $ 10,000

X

- References
No definition available.
+ Details

Name: fil_CorrectionOfInterimCondensedFinancialStatementsTablesAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22663-107794

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22658-107794
+ Details

Name: us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2

4. STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)
12 Months Ended

Oct. 31, 2015

Oct. 31, 2014

COMMON STOCK TRANSACTIONS:

Authorized to issue shares of common stock 75,000,000 75,000,000

Shares of common stock with a par value per share $ 0.001 $ 0.001

Common Stock, shares issued 10,300,000 10,300,000

Common Stock, shares Outstanding 10,300,000 10,300,000

Derivative Liability Addition $ (25,434)

X

- References
No definition available.
+ Details

Name: fil_CommonStockTransactionsAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInDerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2

5. RELATED PARTY TRANSACTIONS (Details Narrative)

Oct. 31, 2015

USD ($)

Thru Pharma

Owed to related party $ 10,232

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(3),(4))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_DueToRelatedPartiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fil_ThruPharmaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2

6. INCOME TAXES (Details Narrative)
12 Months Ended

Oct. 31, 2015

USD ($)

INCOME TAX AS FOLLOWS

Net operating loss carry-forward $ 81,306

Operating Loss Carryforwards, Expiration Net operating loss carry-forward may be used to offset future taxable income and begins to expire in 2031.

X

- References
No definition available.
+ Details

Name: fil_IncomeTaxAsFollowsAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingLossCarryforwardsLimitationsOnUse

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2

10. FAIR VALUE MEASUREMENT (Details) - USD ($)

Oct. 31, 2015

Oct. 31, 2014

Derivative Liability $ 5,500 $ 0

Fair Value, Inputs, Level 1 [Member]

Derivative Liability 0 0

Fair Value, Inputs, Level 2 [Member]

Derivative Liability 5,500 0

Fair Value, Inputs, Level 3 [Member]

Derivative Liability $ 0 $ 0

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226008-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13495-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958
+ Details

Name: us-gaap_DerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 38 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2

11. STOCK PURCHASE OPTIONS AND WARRANTS (Details)
12 Months Ended

Oct. 31, 2015

Oct. 31, 2014

Stock Option [Member]

Expected stock price volatility, minimum 203.00%

Expected stock price volatility, maximum 213.00%

Expected stock price volatility

Expected dividends 0.00%

Expected term 3 years

Risk-free interest rate, minimum 0.80%

Risk-free interest rate, maximum 1.09%

Risk-free interest rate

Warrant [Member]

Expected stock price volatility 212.00%

Expected dividends 0.00%

Risk-free interest rate 1.08%

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 14.D.2)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14
-Section D
-Subsection 2
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_StockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2

11. STOCK PURCHASE OPTIONS AND WARRANTS (Details 1)
12 Months Ended

Oct. 31, 2015

USD ($)

$ / shares

shares

Stock Option [Member]

Number of Options Outstanding, Beginning | shares 0

Number of Options Granted | shares 37,500

Number of Options Exercised | shares 0

Number of Options expired or cancelled | shares 0

Number of Options Outstanding, Ending | shares 37,500

Weighted Average Exercise Price Outstanding, Beginning $ 0.00

Weighted Average Exercise Price Granted .80

Weighted Average Exercise Price Exercised 0.00

Weighted Average Exercise Price expired or Canceled 0.00

Weighted Average Exercise Price Outstanding, Ending .80

Weighted Average Grant Date Fair Value Outstanding, Beginning .00

Weighted Average Grant Date Fair Value Granted .41

Weighted Average Grant Date Fair Value Exercised 0.00

Weighted Average Grant Date Fair Value expired or Canceled 0.00

Weighted Average Grant Date Fair Value Outstanding, Ending $ .41

Expiration Date Outstanding, Beginning 0 years

Expiration Date Granted 2 years 7 months 20 days

Expiration Date Outstanding, Ending 2 years 5 months 19 days

Value if Exercised Outstanding, Beginning | $ $ 0

Value if Exercised Granted | $ 30,000

Value if Exercised Outstanding, Ending | $ $ 30,000

Warrant [Member]

Number of Options Outstanding, Beginning | shares 0

Number of Options Granted | shares 600,000

Number of Options Exercised | shares 0

Number of Options expired or cancelled | shares 0

Number of Options Outstanding, Ending | shares 600,000

Weighted Average Exercise Price Outstanding, Beginning $ 0.00

Weighted Average Exercise Price Granted .80

Weighted Average Exercise Price Exercised 0.00

Weighted Average Exercise Price expired or Canceled 0.00

Weighted Average Exercise Price Outstanding, Ending .80

Weighted Average Grant Date Fair Value Outstanding, Beginning 0.00

Weighted Average Grant Date Fair Value Granted .36

Weighted Average Grant Date Fair Value Exercised 0.00

Weighted Average Grant Date Fair Value expired or Canceled 0.00

Weighted Average Grant Date Fair Value Outstanding, Ending $ .36

Expiration Date Outstanding, Beginning 0 years

Expiration Date Granted 8 months 23 days

Expiration Date Outstanding, Ending 8 months 23 days

Value if Exercised Outstanding, Beginning | $ $ 0

Value if Exercised Granted | $ 480,000

Value if Exercised Outstanding, Ending | $ $ 480,000

X

- Definition
Custom Element.
+ References
No definition available.
+ Details

Name: fil_NumberOfOptionsExercised

Namespace Prefix: fil_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantDateFairValue

Namespace Prefix: fil_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: fil_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodGrantDateFairValue

Namespace Prefix: fil_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodGrantDateFairValue

Namespace Prefix: fil_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue

Namespace Prefix: fil_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm

Namespace Prefix: fil_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1

Namespace Prefix: fil_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_ValueIfExercisedGranted

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_ValueIfExercisedOutstanding

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(4)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_StockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 40 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2

12. RESTATEMENT OF FINANCIAL STATEMENTS (Details) - USD ($)

Oct. 31, 2015

Oct. 31, 2014

Loan from related party $ 37,682 $ 45,458

Convertible Notes payable, net of $36,578 debt discount 69,312 0

Accrued Interest Payable 1,923 0

Derivative Liability 5,500 0

Total Current Liabilities 114,417 45,458

Total Liabilities 114,417 45,458

Stock Subscription Payable 50,281 0

Accumulated deficit (433,562) (81,306)

Total Stockholders' Deficit (114,417) $ (45,458)

As Reported [Member]

Loan from related party 75,232

Convertible Notes payable, net of $36,578 debt discount 0

Accrued Interest Payable 0

Derivative Liability 0

Total Current Liabilities 75,232

Total Liabilities 75,232

Stock Subscription Payable 0

Accumulated deficit (111,080)

Total Stockholders' Deficit (111,080)

Correction [Member]

Loan from related party (37,550)

Convertible Notes payable, net of $36,578 debt discount 69,312

Accrued Interest Payable 1,923

Derivative Liability 5,500

Total Current Liabilities 39,185

Total Liabilities 39,185

Stock Subscription Payable 50,281

Accumulated deficit (322,482)

Total Stockholders' Deficit $ (3,337)

X

- References
No definition available.
+ Details

Name: fil_StockSubscriptionPayable

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ConvertibleNotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13495-108611
+ Details

Name: us-gaap_DerivativeLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a)(5))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_NotesPayableRelatedPartiesClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=us-gaap_ScenarioPreviouslyReportedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=us-gaap_RestatementAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 41 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2

12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 1) - USD ($)
12 Months Ended

Oct. 31, 2015

Oct. 31, 2014

Professional Fees $ 328,640 $ 49,813

TOTAL OPERATING EXPENSES 328,640 50,294

NET LOSS FROM OPERATIONS (328,640) (50,294)

Interest Expense (18,116) 0

Derivative expense 25,434 0

Change in Fair Value of Derivative 19,934 0

TOTAL OTHER INCOME (23,616) 0

NET LOSS BEFORE INCOME TAXES (352,256) (50,294)

NET LOSS $ (352,256) $ (50,294)

NET LOSS PER SHARE: BASIC AND DILUTED $ (.03) $ (0.00) ^[1]

As Reported [Member]

Professional Fees $ 29,774

TOTAL OPERATING EXPENSES 29,774

NET LOSS FROM OPERATIONS (29,774)

Interest Expense 0

Derivative expense 0

Change in Fair Value of Derivative 0

TOTAL OTHER INCOME 0

NET LOSS BEFORE INCOME TAXES (29,774)

NET LOSS $ (29,774)

NET LOSS PER SHARE: BASIC AND DILUTED $ (0.00)

Correction [Member]

Professional Fees $ 298,866

TOTAL OPERATING EXPENSES 298,866

NET LOSS FROM OPERATIONS (298,866)

Interest Expense (18,116)

Derivative expense (25,434)

Change in Fair Value of Derivative 19,934

TOTAL OTHER INCOME (23,616)

NET LOSS BEFORE INCOME TAXES (322,482)

NET LOSS $ (322,482)

NET LOSS PER SHARE: BASIC AND DILUTED $ (.03)

[1] Denotes a loss of less than $(0.01) per share

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of unrealized gain (loss) recognized in the income statement for a financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Interest expense incurred on short positions arising from sales of securities and other assets, which the entity does not own, to other parties. Trading liabilities includes the fair value of derivative contracts held for trading that are in loss positions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.7)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpenseTradingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.4)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_OtherIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07.2(a),(b),(c),(d))
-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 225
-Section 45
-Paragraph 3
-Subparagraph (k)
-URI http://asc.fasb.org/extlink&oid=6488370&loc=d3e13550-115849
+ Details

Name: us-gaap_ProfessionalFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=us-gaap_ScenarioPreviouslyReportedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=us-gaap_RestatementAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 42 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2

12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 2) - USD ($)
12 Months Ended

Oct. 31, 2015

Oct. 31, 2014

Oct. 31, 2013

Stock for Compensation $ 38,400 $ 0

Stock as Incentive for Convertible Note 11,881

Options Granted for Compensation 16,217 0

Warrants Issued for Compensation 216,799 0

Derivative Liability Addition 25,434

Net loss for the period (352,256) (50,294)

Ending Balance, Amount (114,417) (45,458)

As Reported [Member]

Stock for Compensation 0

Stock as Incentive for Convertible Note 0

Options Granted for Compensation 0

Warrants Issued for Compensation 0

Derivative Liability Addition 0

Net loss for the period (29,774)

Ending Balance, Amount (111,080)

Correction [Member]

Stock for Compensation 38,400

Stock as Incentive for Convertible Note 11,881

Options Granted for Compensation 16,217

Warrants Issued for Compensation 216,799

Derivative Liability Addition 25,434

Net loss for the period (322,482)

Ending Balance, Amount (3,337)

Additional Paid-in Capital

Stock as Incentive for Convertible Note 0

Options Granted for Compensation 16,217

Warrants Issued for Compensation 216,799

Net loss for the period 0

Ending Balance, Amount 258,564 25,548 $ 20,700

Additional Paid-in Capital | As Reported [Member]

Stock as Incentive for Convertible Note 0

Options Granted for Compensation 0

Warrants Issued for Compensation 0

Net loss for the period 0

Ending Balance, Amount 25,548

Additional Paid-in Capital | Correction [Member]

Stock as Incentive for Convertible Note 0

Options Granted for Compensation 16,217

Warrants Issued for Compensation 216,799

Net loss for the period 0

Ending Balance, Amount 252,642

Stock Subscription Payable

Stock for Compensation 38,400

Stock as Incentive for Convertible Note 11,881

Options Granted for Compensation 0

Warrants Issued for Compensation 0

Net loss for the period 0

Ending Balance, Amount 50,281

Stock Subscription Payable | As Reported [Member]

Stock as Incentive for Convertible Note 0

Options Granted for Compensation 0

Warrants Issued for Compensation 0

Net loss for the period 0

Ending Balance, Amount 0

Stock Subscription Payable | Correction [Member]

Stock as Incentive for Convertible Note 11,881

Options Granted for Compensation 0

Warrants Issued for Compensation 0

Net loss for the period 0

Ending Balance, Amount 50,281

Accumulated Deficit

Stock as Incentive for Convertible Note 0

Options Granted for Compensation 0

Warrants Issued for Compensation 0

Net loss for the period (352,256) (50,294)

Ending Balance, Amount (433,562) (81,306) (31,012)

Accumulated Deficit | As Reported [Member]

Stock as Incentive for Convertible Note 0

Options Granted for Compensation 0

Warrants Issued for Compensation 0

Net loss for the period (29,774)

Ending Balance, Amount (111,080)

Accumulated Deficit | Correction [Member]

Stock as Incentive for Convertible Note 0

Options Granted for Compensation 0

Warrants Issued for Compensation 0

Net loss for the period (322,482)

Ending Balance, Amount (322,482)

Total Stockholders' Deficit

Stock for Compensation 38,400

Stock as Incentive for Convertible Note 11,881

Options Granted for Compensation 16,217

Warrants Issued for Compensation 216,799

Net loss for the period (352,256) (50,294)

Ending Balance, Amount (114,417) $ (45,458) $ (12)

Total Stockholders' Deficit | As Reported [Member]

Stock as Incentive for Convertible Note 0

Options Granted for Compensation 0

Warrants Issued for Compensation 0

Net loss for the period (29,774)

Ending Balance, Amount (75,232)

Total Stockholders' Deficit | Correction [Member]

Stock as Incentive for Convertible Note 11,881

Options Granted for Compensation 61,277

Warrants Issued for Compensation 216,799

Net loss for the period (322,482)

Ending Balance, Amount $ (39,185)

X

- References
No definition available.
+ Details

Name: fil_OptionsGrantedForCompensation

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_StockAsIncentiveForConvertibleNote

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_WarrantsIssuedForCompensation

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInDerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value, after forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 30
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51830203&loc=d3e3913-113898

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 30
-Section 35
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418191&loc=d3e15009-113911
+ Details

Name: us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=us-gaap_ScenarioPreviouslyReportedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=us-gaap_RestatementAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=fil_StockSubscriptionPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 43 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2

12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 3) - USD ($)
12 Months Ended

Oct. 31, 2015

Oct. 31, 2014

Net loss for the period $ (361,103) $ (50,294)

Stock for comepensation 38,400 0

Derivative liability addition 25,434

Related party payable receivable 27,450

Options granted for compensation 16,217 0

Warrants issued for professional fees 216,799 0

Change in Fair Value of Derivative (19,934) 0

Amortization of debt discount 16,193 0

Accrued Interest Payable 1,923 0

Net cash used in operating activities (29,774) (49,837)

Proceeds from convertible note 65,000 0

Proceeds from convertible note 65,000

Payments to related party (65,000) 0

Net cash flows from financing activities 29,774 46,085

Original Issue Discount 10,000 0

Stock as Incentive for Convertible Note 11,881

Total Noncash Investing and Financing Activities 21,881 $ 5,276

As Reported [Member]

Net loss for the period (29,774)

Stock for comepensation 0

Derivative liability addition 0

Related party payable receivable 0

Options granted for compensation 0

Warrants issued for professional fees 0

Change in Fair Value of Derivative 0

Amortization of debt discount 0

Accrued Interest Payable 0

Net cash used in operating activities (29,774)

Proceeds from convertible note 29,774

Proceeds from convertible note 0

Payments to related party 0

Net cash flows from financing activities 29,774

Original Issue Discount 0

Stock as Incentive for Convertible Note 0

Total Noncash Investing and Financing Activities 0

Correction [Member]

Net loss for the period (322,482)

Stock for comepensation 38,400

Derivative liability addition 25,434

Related party payable receivable 27,450

Options granted for compensation 16,217

Warrants issued for professional fees 216,799

Change in Fair Value of Derivative (19,934)

Amortization of debt discount 16,193

Accrued Interest Payable 1,923

Net cash used in operating activities 0

Proceeds from convertible note 0

Proceeds from convertible note 65,000

Payments to related party (65,000)

Net cash flows from financing activities 0

Original Issue Discount 10,000

Stock as Incentive for Convertible Note 11,881

Total Noncash Investing and Financing Activities $ 21,881

X

- References
No definition available.
+ Details

Name: fil_OptionsGrantedForCompensation

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_OriginalInterestDiscount

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_ProceedsFromConvertibleNote

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_StockAsIncentiveForConvertibleNote

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_TotalNoncashInvestingAndFinancingActivities

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: fil_WarrantsIssuedForCompensation

Namespace Prefix: fil_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of unrealized gain (loss) recognized in the income statement for a financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInDerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromConvertibleDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_RepaymentsOfRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value, after forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 30
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51830203&loc=d3e3913-113898

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 30
-Section 35
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418191&loc=d3e15009-113911
+ Details

Name: us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=us-gaap_ScenarioPreviouslyReportedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=us-gaap_RestatementAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 62 136 1 true 13 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://araxholdings.com/20140430/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED BALANCE SHEETS Sheet http://araxholdings.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://araxholdings.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://araxholdings.com/role/CondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT Sheet http://araxholdings.com/role/CondensedStatementOfChangesInStockholdersDeficit CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 00000006 - Statement - CONDENSED STATEMENTS OF CASH FLOWS Sheet http://araxholdings.com/role/CondensedStatementsOfCashFlows CONDENSED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Disclosure - 1. ORGANIZATION AND NATURE OF BUSINESS Sheet http://araxholdings.com/20140430/role/idr_DisclosureORGANIZATIONANDNATUREOFBUSINESS 1. ORGANIZATION AND NATURE OF BUSINESS Notes 7 false false R8.htm 00000008 - Disclosure - 2. GOING CONCERN Sheet http://araxholdings.com/20140430/role/idr_DisclosureGOINGCONCERN 2. GOING CONCERN Notes 8 false false R9.htm 00000009 - Disclosure - 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://araxholdings.com/20140430/role/idr_DisclosureSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - 4. STOCKHOLDERS' DEFICIT Sheet http://araxholdings.com/role/StockholdersDeficit 4. STOCKHOLDERS' DEFICIT Notes 10 false false R11.htm 00000011 - Disclosure - 5. RELATED PARTY TRANSACTIONS Sheet http://araxholdings.com/20140430/role/idr_DisclosureRELATEDPARTYTRANSACTION 5. RELATED PARTY TRANSACTIONS Notes 11 false false R12.htm 00000012 - Disclosure - 6. INCOME TAXES Sheet http://araxholdings.com/20140430/role/idr_DisclosureINCOMETAXES 6. INCOME TAXES Notes 12 false false R13.htm 00000013 - Disclosure - 7. COMMITMENTS AND CONTINGENCIES Sheet http://araxholdings.com/role/CommitmentsAndContingencies 7. COMMITMENTS AND CONTINGENCIES Notes 13 false false R14.htm 00000014 - Disclosure - 8. SUBSEQUENT EVENTS Sheet http://araxholdings.com/role/SubsequentEvents 8. SUBSEQUENT EVENTS Notes 14 false false R15.htm 00000015 - Disclosure - 9. CONVERTIBLE DEBT AND DERIVATIVE LIABILITIES Sheet http://araxholdings.com/role/ConvertibleDebtAndDerivativeLiabilities 9. CONVERTIBLE DEBT AND DERIVATIVE LIABILITIES Notes 15 false false R16.htm 00000016 - Disclosure - 10. FAIR VALUE MEASUREMENT Sheet http://araxholdings.com/role/FairValueMeasurement 10. FAIR VALUE MEASUREMENT Notes 16 false false R17.htm 00000017 - Disclosure - 11. STOCK PURCHASE OPTIONS AND WARRANTS Sheet http://araxholdings.com/role/StockPurchaseOptionsAndWarrants 11. STOCK PURCHASE OPTIONS AND WARRANTS Notes 17 false false R18.htm 00000018 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS Sheet http://araxholdings.com/role/RestatementOfFinancialStatements 12. RESTATEMENT OF FINANCIAL STATEMENTS Notes 18 false false R19.htm 00000019 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://araxholdings.com/20140430/role/idr_DisclosureSIGNIFICANTACCOUNTINGPOLICIESPolicies 3. SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 19 false false R20.htm 00000020 - Disclosure - 10. FAIR VALUE MEASUREMENT (Tables) Sheet http://araxholdings.com/role/FairValueMeasurementTables 10. FAIR VALUE MEASUREMENT (Tables) Tables http://araxholdings.com/role/FairValueMeasurement 20 false false R21.htm 00000021 - Disclosure - 11. STOCK PURCHASE OPTIONS AND WARRANTS (Tables) Sheet http://araxholdings.com/role/StockPurchaseOptionsAndWarrantsTables 11. STOCK PURCHASE OPTIONS AND WARRANTS (Tables) Tables http://araxholdings.com/role/StockPurchaseOptionsAndWarrants 21 false false R22.htm 00000022 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Tables) Sheet http://araxholdings.com/role/RestatementOfFinancialStatementsTables 12. RESTATEMENT OF FINANCIAL STATEMENTS (Tables) Tables http://araxholdings.com/role/RestatementOfFinancialStatements 22 false false R23.htm 00000023 - Statement - 4. STOCKHOLDERS' DEFICIT (Details Narrative) Sheet http://araxholdings.com/role/StockholdersDeficitDetailsNarrative 4. STOCKHOLDERS' DEFICIT (Details Narrative) Details http://araxholdings.com/role/StockholdersDeficit 23 false false R24.htm 00000024 - Statement - 5. RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://araxholdings.com/20140430/role/idr_RELATEDPARTYTRANSACTIONSDetails 5. RELATED PARTY TRANSACTIONS (Details Narrative) Details http://araxholdings.com/20140430/role/idr_DisclosureRELATEDPARTYTRANSACTION 24 false false R25.htm 00000025 - Statement - 6. INCOME TAXES (Details Narrative) Sheet http://araxholdings.com/role/IncomeTaxesDetailsNarrative 6. INCOME TAXES (Details Narrative) Details http://araxholdings.com/20140430/role/idr_DisclosureINCOMETAXES 25 false false R26.htm 00000026 - Disclosure - 10. FAIR VALUE MEASUREMENT (Details) Sheet http://araxholdings.com/role/FairValueMeasurementDetails 10. FAIR VALUE MEASUREMENT (Details) Details http://araxholdings.com/role/FairValueMeasurementTables 26 false false R27.htm 00000027 - Disclosure - 11. STOCK PURCHASE OPTIONS AND WARRANTS (Details) Sheet http://araxholdings.com/role/StockPurchaseOptionsAndWarrantsDetails 11. STOCK PURCHASE OPTIONS AND WARRANTS (Details) Details http://araxholdings.com/role/StockPurchaseOptionsAndWarrantsTables 27 false false R28.htm 00000028 - Disclosure - 11. STOCK PURCHASE OPTIONS AND WARRANTS (Details 1) Sheet http://araxholdings.com/role/StockPurchaseOptionsAndWarrantsDetails1 11. STOCK PURCHASE OPTIONS AND WARRANTS (Details 1) Details http://araxholdings.com/role/StockPurchaseOptionsAndWarrantsTables 28 false false R29.htm 00000029 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details) Sheet http://araxholdings.com/role/RestatementOfFinancialStatementsDetails 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details) Details http://araxholdings.com/role/RestatementOfFinancialStatementsTables 29 false false R30.htm 00000030 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 1) Sheet http://araxholdings.com/role/RestatementOfFinancialStatementsDetails1 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 1) Details http://araxholdings.com/role/RestatementOfFinancialStatementsTables 30 false false R31.htm 00000031 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 2) Sheet http://araxholdings.com/role/RestatementOfFinancialStatementsDetails2 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 2) Details http://araxholdings.com/role/RestatementOfFinancialStatementsTables 31 false false R32.htm 00000032 - Disclosure - 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 3) Sheet http://araxholdings.com/role/RestatementOfFinancialStatementsDetails3 12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 3) Details http://araxholdings.com/role/RestatementOfFinancialStatementsTables 32 false false All Reports Book All Reports fil-20151031.xml fil-20151031.xsd fil-20151031_cal.xml fil-20151031_def.xml fil-20151031_lab.xml fil-20151031_pre.xml true true ZIP 50 0001019056-16-001402-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019056-16-001402-xbrl.zip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ü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end

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Oct. 31, 2015	Feb. 12, 2016	Apr. 30, 2015
Document and Entity Information:
Entity Registrant Name	Arax Holdings Corp
Document Type	10-K/A
Document Period End Date	Oct. 31, 2015
Amendment Flag	true
Amendment Description	The purpose of this Amendment No. 1 (the “Amendment”) to the registrant’s Annual Report on Form 10-K for the year ended October 31, 2015, filed with the Securities and Exchange Commission on February 16, 2016 (the “Annual Report”), is to record related party payables due to two consultants under consulting agreements with Thru Pharma to be paid with 7,500 options for the first consultant on a monthly basis convertible at $.80 per share entered into in February 2015 and the other to be paid in 10,000 common shares as stock payable, and record a management estimate of 25% of their overall compensation as a consulting expense. The Company issued 600,000 warrants on September 22, 2015 as payment for legal expenses that had not been recorded. The Company also entered into a convertible note agreement that previously had not been recorded that is considered a derivative or contains embedded features subject to derivative accounting related to a revolving convertible note in which the Company can borrow up to $200,000, which includes a 10% OID. The Company issued the first tranche of the convertible note totaling $75,000, of which $65,000 was paid in cash, $2,500 was paid for legal fees, and a OID of $7,500, which included a ratchet provision in the conversion price of $.95 or a price equal to 60% of the last equity transaction completed by the Company as part of a subscription agreement. The note has a maturity date of nine months after funding and also includes a fifty percent premium totaling $37,500 which is added on 90 days after funding. The fair values of the derivative instruments are measured each quarter, which resulted in a gain of $19,934 and derivative expense of $25,434 during the year ended October 31, 2015. As of October 31, 2015, the fair market value of the derivatives aggregated $5,500 using the following assumptions: estimated 0.42 to 0.75-year term, estimated volatility of 133.49% to 243.69%, and a discount rate of 0.21% to 0.23%. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881. No other changes have been made to the Annual Report except as noted above. This Amendment to the Annual Report speaks as of the original filing date of the Annual Report, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Annual Report except that changes have been made to the cover page, Note 9 – Convertible Debt and Derivative Liabilities, Note 10 - Fair Value Measurement, Note 11 – Stock Purchase Options and Warrants, and Note 12 – Correction of Financial Statements.
Entity Central Index Key	0001566243
Current Fiscal Year End Date	--10-31
Entity Public Float			$ 920,000
Entity Common Stock, Shares Outstanding		10,355,294
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	FY

CONDENSED BALANCE SHEETS - USD ($)	Oct. 31, 2015	Oct. 31, 2014
Current Assets
Total Current Assets	$ 0	$ 0
Fixed Assets
Total Assets	0	0
Current Liabilities
Loan from related party	37,682	45,458
Convertible Notes payable, net of $41,797 debt discount	69,312	0
Accrued Interest Payable	1,923	0
Derivative Liability	5,500	0
Total Current Liabilities	114,417	45,458
Total Liabilities	114,417	45,458
Commitments and Contingencies
Stockholders' Deficit:
Common stock, $0.001 par value; 75,000,000 shares authorized; 10,300,000 shares issued and outstanding	10,300	10,300
Additional paid in capital	258,564	25,548
Stock Subscription Payable	50,281	0
Accumulated deficit	(433,562)	(81,306)
Total Stockholders' Deficit	(114,417)	(45,458)
Total Liabilities and Stockholders' Equity	$ 0	$ 0

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)	Oct. 31, 2015	Oct. 31, 2014
Assets [Abstract]
Discount on convertible note payable	$ 41,797	$ 0
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	75,000,000	75,000,000
Common Stock, shares issued	10,300,000	10,300,000
Common Stock, shares Outstanding	10,300,000	10,300,000

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Common Stock	Additional Paid-in Capital	Stock Subscription Payable	Accumulated Deficit	Total Stockholders' Deficit
Beginning Balance, Shares at Oct. 31, 2013	10,300,000
Beginning Balance, Amount at Oct. 31, 2013	$ 10,300	$ 20,700		$ (31,012)	$ (12)
Forgiveness of related-party loan payable		4,848			4,848
Net loss for the period				(50,294)	(50,294)
Ending Balance, Shares at Oct. 31, 2014	10,300,000
Ending Balance, Amount at Oct. 31, 2014	$ 10,300	25,548		(81,306)	(45,458)
Stock as Incentive for Convertible Note		0	$ 11,881	0	11,881
Stock for compensation			38,400		38,400
Options Granted for Compensation		16,217	0	0	16,217
Warrants Issued for Compensation		216,799	0	0	216,799
Net loss for the period		0	0	(352,256)	(352,256)
Ending Balance, Shares at Oct. 31, 2015	10,300,000
Ending Balance, Amount at Oct. 31, 2015	$ 10,300	$ 258,564	$ 50,281	$ (433,562)	$ (114,417)

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Oct. 31, 2015	Oct. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	$ (361,103)	$ (50,294)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock for Compensation	38,400	0
Derivative Expense	25,434	0
Related party payable for services	27,450
Options granted for compensation	16,217	0
Warrants issued for professional fees	216,799	0
Change in Fair Value of Derivative	(19,934)	0
Amortization of debt discount	16,193	0
Depreciation expense	0	29
Loss on disposal of fixed assets	0	428
Changes in operating assets and liabilities:
Accrued Interest Payable	1,923	0
NET CASH USED IN OPERATING ACTIVITIES	(29,774)	(49,837)
CASH FLOWS FROM INVESTING ACTIVITIES
NET CASH FLOWS FROM INVESTING ACTIVITIES	0	0
CASH FLOWS FROM FINANCING ACTIVITIES
Loan from related party	29,774	46,085
Proceeds from convertible note	65,000	0
Payments to related party	(65,000)	0
NET CASH FLOWS FROM FINANCING ACTIVITIES	29,774	46,085
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	0	(3,752)
Cash, beginning of period	0	3,752
Cash, end of period	0	0
SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION
Interest paid	0	0
Income taxes paid	0	0
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Original Issue Discount	10,000	0
Stock as Incentive for Convertible Note	11,881
Disposal of equipment without cash proceeds	0	428
Forgiveness of loan from related party	0	4,848
Total Noncash Investing and Financing Activities	$ 21,881	$ 5,276

8. SUBSEQUENT EVENTS	12 Months Ended
8. SUBSEQUENT EVENTS	Oct. 31, 2015
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	In accordance with ASC 855-10, “Subsequent Events” the Company has analyzed its operations subsequent to October 31, 2015 to the date these financial statements were issued. Subsequent to the year ending October 31, 2015, 35,294 shares of common stock were issued on February 5, 2016. The shares were issued as part of an incentive to enter into convertible notes that were owed as of October 31, 2015, with a relative fair value of $11,881.

4. STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	12 Months Ended
4. STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	Oct. 31, 2015	Oct. 31, 2014
COMMON STOCK TRANSACTIONS:
Authorized to issue shares of common stock	75,000,000	75,000,000
Shares of common stock with a par value per share	$ 0.001	$ 0.001
Common Stock, shares issued	10,300,000	10,300,000
Common Stock, shares Outstanding	10,300,000	10,300,000
Derivative Liability Addition	$ (25,434)

6. INCOME TAXES (Details Narrative)	12 Months Ended
6. INCOME TAXES (Details Narrative)	Oct. 31, 2015 USD ($)
INCOME TAX AS FOLLOWS
Net operating loss carry-forward	$ 81,306
Operating Loss Carryforwards, Expiration	Net operating loss carry-forward may be used to offset future taxable income and begins to expire in 2031.

10. FAIR VALUE MEASUREMENT (Details) - USD ($)	Oct. 31, 2015	Oct. 31, 2014
Derivative Liability	$ 5,500	$ 0
Fair Value, Inputs, Level 1 [Member]
Derivative Liability	0	0
Fair Value, Inputs, Level 2 [Member]
Derivative Liability	5,500	0
Fair Value, Inputs, Level 3 [Member]
Derivative Liability	$ 0	$ 0

11. STOCK PURCHASE OPTIONS AND WARRANTS (Details)	12 Months Ended
11. STOCK PURCHASE OPTIONS AND WARRANTS (Details)	Oct. 31, 2015	Oct. 31, 2014
Stock Option [Member]
Expected stock price volatility, minimum	203.00%
Expected stock price volatility, maximum	213.00%
Expected stock price volatility
Expected dividends	0.00%
Expected term	3 years
Risk-free interest rate, minimum	0.80%
Risk-free interest rate, maximum	1.09%
Risk-free interest rate
Warrant [Member]
Expected stock price volatility	212.00%
Expected dividends	0.00%
Risk-free interest rate	1.08%

11. STOCK PURCHASE OPTIONS AND WARRANTS (Details 1)	12 Months Ended
11. STOCK PURCHASE OPTIONS AND WARRANTS (Details 1)	Oct. 31, 2015 USD ($) $ / shares shares
Stock Option [Member]
Number of Options Outstanding, Beginning \| shares	0
Number of Options Granted \| shares	37,500
Number of Options Exercised \| shares	0
Number of Options expired or cancelled \| shares	0
Number of Options Outstanding, Ending \| shares	37,500
Weighted Average Exercise Price Outstanding, Beginning	$ 0.00
Weighted Average Exercise Price Granted	.80
Weighted Average Exercise Price Exercised	0.00
Weighted Average Exercise Price expired or Canceled	0.00
Weighted Average Exercise Price Outstanding, Ending	.80
Weighted Average Grant Date Fair Value Outstanding, Beginning	.00
Weighted Average Grant Date Fair Value Granted	.41
Weighted Average Grant Date Fair Value Exercised	0.00
Weighted Average Grant Date Fair Value expired or Canceled	0.00
Weighted Average Grant Date Fair Value Outstanding, Ending	$ .41
Expiration Date Outstanding, Beginning	0 years
Expiration Date Granted	2 years 7 months 20 days
Expiration Date Outstanding, Ending	2 years 5 months 19 days
Value if Exercised Outstanding, Beginning \| $	$ 0
Value if Exercised Granted \| $	30,000
Value if Exercised Outstanding, Ending \| $	$ 30,000
Warrant [Member]
Number of Options Outstanding, Beginning \| shares	0
Number of Options Granted \| shares	600,000
Number of Options Exercised \| shares	0
Number of Options expired or cancelled \| shares	0
Number of Options Outstanding, Ending \| shares	600,000
Weighted Average Exercise Price Outstanding, Beginning	$ 0.00
Weighted Average Exercise Price Granted	.80
Weighted Average Exercise Price Exercised	0.00
Weighted Average Exercise Price expired or Canceled	0.00
Weighted Average Exercise Price Outstanding, Ending	.80
Weighted Average Grant Date Fair Value Outstanding, Beginning	0.00
Weighted Average Grant Date Fair Value Granted	.36
Weighted Average Grant Date Fair Value Exercised	0.00
Weighted Average Grant Date Fair Value expired or Canceled	0.00
Weighted Average Grant Date Fair Value Outstanding, Ending	$ .36
Expiration Date Outstanding, Beginning	0 years
Expiration Date Granted	8 months 23 days
Expiration Date Outstanding, Ending	8 months 23 days
Value if Exercised Outstanding, Beginning \| $	$ 0
Value if Exercised Granted \| $	480,000
Value if Exercised Outstanding, Ending \| $	$ 480,000

12. RESTATEMENT OF FINANCIAL STATEMENTS (Details) - USD ($)	Oct. 31, 2015	Oct. 31, 2014
Loan from related party	$ 37,682	$ 45,458
Convertible Notes payable, net of $36,578 debt discount	69,312	0
Accrued Interest Payable	1,923	0
Derivative Liability	5,500	0
Total Current Liabilities	114,417	45,458
Total Liabilities	114,417	45,458
Stock Subscription Payable	50,281	0
Accumulated deficit	(433,562)	(81,306)
Total Stockholders' Deficit	(114,417)	$ (45,458)
As Reported [Member]
Loan from related party	75,232
Convertible Notes payable, net of $36,578 debt discount	0
Accrued Interest Payable	0
Derivative Liability	0
Total Current Liabilities	75,232
Total Liabilities	75,232
Stock Subscription Payable	0
Accumulated deficit	(111,080)
Total Stockholders' Deficit	(111,080)
Correction [Member]
Loan from related party	(37,550)
Convertible Notes payable, net of $36,578 debt discount	69,312
Accrued Interest Payable	1,923
Derivative Liability	5,500
Total Current Liabilities	39,185
Total Liabilities	39,185
Stock Subscription Payable	50,281
Accumulated deficit	(322,482)
Total Stockholders' Deficit	$ (3,337)

12. RESTATEMENT OF FINANCIAL STATEMENTS (Details 2) - USD ($)	12 Months Ended
	Oct. 31, 2015	Oct. 31, 2014	Oct. 31, 2013
Stock for Compensation	$ 38,400	$ 0
Stock as Incentive for Convertible Note	11,881
Options Granted for Compensation	16,217	0
Warrants Issued for Compensation	216,799	0
Derivative Liability Addition	25,434
Net loss for the period	(352,256)	(50,294)
Ending Balance, Amount	(114,417)	(45,458)
As Reported [Member]
Stock for Compensation	0
Stock as Incentive for Convertible Note	0
Options Granted for Compensation	0
Warrants Issued for Compensation	0
Derivative Liability Addition	0
Net loss for the period	(29,774)
Ending Balance, Amount	(111,080)
Correction [Member]
Stock for Compensation	38,400
Stock as Incentive for Convertible Note	11,881
Options Granted for Compensation	16,217
Warrants Issued for Compensation	216,799
Derivative Liability Addition	25,434
Net loss for the period	(322,482)
Ending Balance, Amount	(3,337)
Additional Paid-in Capital
Stock as Incentive for Convertible Note	0
Options Granted for Compensation	16,217
Warrants Issued for Compensation	216,799
Net loss for the period	0
Ending Balance, Amount	258,564	25,548	$ 20,700
Additional Paid-in Capital \| As Reported [Member]
Stock as Incentive for Convertible Note	0
Options Granted for Compensation	0
Warrants Issued for Compensation	0
Net loss for the period	0
Ending Balance, Amount	25,548
Additional Paid-in Capital \| Correction [Member]
Stock as Incentive for Convertible Note	0
Options Granted for Compensation	16,217
Warrants Issued for Compensation	216,799
Net loss for the period	0
Ending Balance, Amount	252,642
Stock Subscription Payable
Stock for Compensation	38,400
Stock as Incentive for Convertible Note	11,881
Options Granted for Compensation	0
Warrants Issued for Compensation	0
Net loss for the period	0
Ending Balance, Amount	50,281
Stock Subscription Payable \| As Reported [Member]
Stock as Incentive for Convertible Note	0
Options Granted for Compensation	0
Warrants Issued for Compensation	0
Net loss for the period	0
Ending Balance, Amount	0
Stock Subscription Payable \| Correction [Member]
Stock as Incentive for Convertible Note	11,881
Options Granted for Compensation	0
Warrants Issued for Compensation	0
Net loss for the period	0
Ending Balance, Amount	50,281
Accumulated Deficit
Stock as Incentive for Convertible Note	0
Options Granted for Compensation	0
Warrants Issued for Compensation	0
Net loss for the period	(352,256)	(50,294)
Ending Balance, Amount	(433,562)	(81,306)	(31,012)
Accumulated Deficit \| As Reported [Member]
Stock as Incentive for Convertible Note	0
Options Granted for Compensation	0
Warrants Issued for Compensation	0
Net loss for the period	(29,774)
Ending Balance, Amount	(111,080)
Accumulated Deficit \| Correction [Member]
Stock as Incentive for Convertible Note	0
Options Granted for Compensation	0
Warrants Issued for Compensation	0
Net loss for the period	(322,482)
Ending Balance, Amount	(322,482)
Total Stockholders' Deficit
Stock for Compensation	38,400
Stock as Incentive for Convertible Note	11,881
Options Granted for Compensation	16,217
Warrants Issued for Compensation	216,799
Net loss for the period	(352,256)	(50,294)
Ending Balance, Amount	(114,417)	$ (45,458)	$ (12)
Total Stockholders' Deficit \| As Reported [Member]
Stock as Incentive for Convertible Note	0
Options Granted for Compensation	0
Warrants Issued for Compensation	0
Net loss for the period	(29,774)
Ending Balance, Amount	(75,232)
Total Stockholders' Deficit \| Correction [Member]
Stock as Incentive for Convertible Note	11,881
Options Granted for Compensation	61,277
Warrants Issued for Compensation	216,799
Net loss for the period	(322,482)
Ending Balance, Amount	$ (39,185)

Stock Type

Name and Address of
Beneficial Owner

Number of Shares of Common Stock
Beneficially Owned and Nature of
Beneficial Ownership

Percentage

Common Stock

Thru Pharma, LLC

2329 N. Career Avenue,

Sioux Falls, SD 57107